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ABSTRACT
The end of neurogenesis in the human brain is marked by the transformation of the neural
progenitors, the radial glial cells, into astrocytes. This event coincides with the reduction of
Reelin expression, a glycoprotein that regulates neuronal migration in the cerebral cortex and
cerebellum. A recent study showed that the dentate gyrus of the adult reeler mice, with
homozygous mutation in the RELIN gene, have reduced neurogenesis relative to the wild type.
Based on the above findings, our first hypothesis states that Reelin expression is important for
the formation of radial glia and the generation of neurons from the neural progenitors. In order to
investigate the role of Reelin in the process of cortical neurogenesis during development, we
used human neural progenitor cells (hNPCs) that were isolated from a fetal cortex. These cells do
not express Reelin. In this study, we show that Reelin addition to these hNPCs in vitro induced
the formation of radial glia and increased neurogenesis significantly.

Next, we investigated the mechanism by which Reelin increases the formation of radial glia and
the generation of neurons. The formation of radial glia is under the control of two pathways,
these are the Reelin and the Notch-1 signaling pathways. Since the level of Notch-1 activation
determines if a cell would become a radial glia or an astrocyte, and since the absence of Reelin
allows the transformation of a radial glia into astrocyte, we hypothesized that Reelin induces the
formation of radial glia via activating Notch-1 signaling. To test this hypothesis, we investigated
the effect of Reelin addition on Notch-1 activation in hNPCs. We found that Reelin addition in
vitro activated Notch-1 signaling by increasing the level of Notch-1 intracellular domain
(NICD). On the other hand, reducing NICD release, by inhibiting γ -secretase activity, inhibited
iii

the Reelin-induced radial glia, confirming that Reelin’s effect on the formation of radial glia is
dependent on Notch-1 activation. Furthermore, we found that the Reelin-induced tyrosine
phosphorylation of Disabled-1 (Dab-1), an adaptor protein downstream of Reelin, and the
subsequent activation of Src family kinases, are essential steps for Notch-1 activation by Reelin.

Finally, we found that Reelin addition increased the binding of Dab-1, recently identified as a
nucleoshuttling protein, to NICD and enhanced NICD translocation to the nucleus. This resulted
in the induction of BLBP expression and the subsequent formation of radial glia. Taken together,
these data show that Reelin signaling, mediated by Dab-1 and Src kinase, activates Notch-1
signaling in hNPCs resulting in the induction of BLBP expression, the formation of radial glia
and the generation of neurons. This work is novel because it provides that first evidence that
Reelin expression is an important signal for the neuronal differentiation of the hNPCs. It also
shows the crosstalk between Reelin and Notch-1 signaling, two major pathways in development
and cell fate determination. The work is significant because it improves our understanding of the
role of Reelin signaling in cell fate determination, differentiation and neurogenesis for the future
manipulation of these processes to restore adult brain functions after brain injury or in
neurodegenerative diseases.
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CHAPTER ONE:
GENERAL INTRODUCTION
Adult Neurogenesis and Radial Glial Cells

Neural stem cells were found in two regions in the adult mammalian brain: the subventricular
zone (SVZ) of the lateral ventricle and the dentate gyrus subgranular zone (SGZ) of the
hippocampus1. Since the discovery of these cells great effort has focused on understanding the
mechanism of neurogenesis to facilitate their therapeutic use in restoring brain functions after
brain injury and in neurodegenerative diseases1. The two challenges are either to stimulate the
endogenous resources to migrate and differentiate into the damaged areas or to expand and
manipulate these cells in-vitro and then transplant them in the desired site. In both cases, success
has been limited due to the lack of the full understanding of the adult’s brain chemistry that
regulates the process of functional neurogenesis1.

Radial glia cells have been recently demonstrated to be the progenitors for the majority of the
central nervous system (CNS) neurons2, 3. They arise early in the development of the CNS from
the neuroepithelial cells that line the ventricles4. These cells were originally studied for their role
in neuronal migration. Radial glia, as their name indicates, extend a long radial process to the
pial surface while having their cell bodies in the ventricular zone (VZ) thus allowing the
migration of the neurons from the VZ to the post-mitotic areas5. However, the finding that these
cells can also give birth to the migratory neurons, via their asymmetric division6, 7, further
highlighted the significance of these cells in brain development. Interestingly, radial glial cells
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disappear or transform into astrocytes in most regions of the mammalian brain after neuronal
generation and migration are completed4.

Many signaling events regulate radial glia differentiation, maturation, maintenance and their
transformation into astrocytes8. Thus the understanding of the mechanisms that induce and
maintain the radial glial phenotype is crucial for the therapeutic manipulation of these cells to
promote neurogenesis and neuronal migration in the adult brain.

Reelin Signaling in Radial Glial Cells

Brain lipid binding protein (BLBP) is a hydrophobic ligand binding protein that is expressed
throughout the CNS in radial glia and astrocytes during development9. BLBP is induced in-vitro
in radial glia by neurons10. A recent elegant study using Cre/loxP fate mapping, showed that all
neuronal population in the mouse brain are derived from radial glial cells expressing BLBP3. It
has been suggested that the induction of BLBP marks the onset of radial glia neurogenesis where
BLBP expression in radial glial cells have been shown to be up-regulated at the onset of
neurogenesis and maintained as neurogenesis proceeds3. Thus, BLBP up-regulation is important
to define the developmental changes that occur in the radial glial cells to drive them into their
neurogenic stage. However, the mechanisms of how this protein mediates its function remain
unknown.

Recently, BLBP expression in cortical radial glia as well as its role in radial process extension
was found to be dependent on Reelin signaling11. Reelin is a large secreted glycoprotein that has
2

been shown to be an important signal for neuronal migration and proper positioning of neurons
in the cerebral cortex and cerebellum12. It’s been proposed that Reelin act as a detachment signal
of the neuron from the radial fibers allowing the positioning of the neurons in an inside-out
manner13. Reelin signal is transmitted into the cells by Disabled-1 (Dab-1), a cytoplasmic
adaptor protein that bind the internalization (NPXY) motif of the lipoprotein receptors,
apolipoprotein receptor2 (ApoER2) and the very low density lipoprotein receptor (VLDLR), via
its phospho-tyrosine binding (PTB) domain14. Tyrosine phosphorylation of Dab-1 is initiated
after Reelin binding to its receptors VLDLR and ApoER215. Dab-1 tyrosine phosphorylation
forms a binding site for Src family kinases resulting in their activation and leading to further
phosphorylation of Dab-1 on its remaining tyrosine residues16, 17. This further activates Src and
ultimately results in the activation of Phosphatidylinositol 3-kinase (P13-K) and Akt

17

. Mice

deficient in VLDLR and ApoER2, Dab1 or Dab1 that cannot be tyrosine phosphorylated
generates a reeler-like phenotype, which is characterized by inversion of the cortical layers and
abnormalities in the laminated brain structures18.

Interestingly, Reelin effect on BLBP expression requires Dab-1 as well, as it failed to occur in
Dab1–/– mice11. Supporting that, reeler and Dab1 mutant mice were shown to exhibit abnormal
development of the radial glia scaffold in the dentate gyrus of the hippocampus, indicating the
importance of this pathway in the formation and maintenance of the radial glial
scaffold19.Components of the Reelin signaling pathway, including VLDLR, ApoER2, and Dab1
were shown to be expressed in both the hippocampal and cortical radial glia19, 20. In addition,
Dab1 was tyrosine phosphorylated in ventricular zone cells upon Reelin stimulation indicating
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that the radial glial cells respond directly to Reelin signal21. Furthermore, a recent study showed
that adult reeler mutants have increased differentiation of the newly generated cells into
astrocytes and decreased differentiation into neurons22.

Taken together, these findings suggest that Reelin signaling does not only regulate the neuronal
migration but it may also regulate the neuronal differentiation via promoting the formation and
maturation of the neural progenitors, the radial glial cells. In this study, we aim to identify the
mechanisms through which Reelin signaling induces and maintains the radial glial phenotype to
promote neurogenesis in human Neural Progenitor Cells (hNPCs).
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Figure 1: A schematic diagram that illustrates the proposed role for Reelin in neurogenesis.
Reelin binding to the surface of a neural progenitor induces BLBP expression in this cell and
drives its transformation into a neurogenic radial glia. The transformation includes
morphological changes and a shift from a proliferative phase (symmetric division) to a
neurogenic phase (asymmetric division) that will result in the generation of neurons. Reelin may
also maintain the neurogenic radial glia by preventing their transformation into astrocytes.

5

Notch-1 Signaling in Radial Glial Cells

A central pathway for the differentiation and maturation of radial glia during development of the
CNS is Notch-1 signaling23-31. Recent studies showed that radial glia differentiation depends on
Notch-1 receptor activation through its direct contact with the migratory neurons that express
Notch-1 ligand, Jagged-125,

26

. In addition, it has been shown that Notch-1 regulates the

morphological differentiation and maturation of radial glia through the transcriptional activation
of BLBP25, 26. Notch-1 activation, upon binding its ligand, will initiate its cleavage by -secretase
to generate Notch-1 intracellular domain (NICD). NICD translocates to the nucleus and binds Cpromoter Binding Factor 1 (CBF1), converting it from transcriptional repressor to transcriptional
activator27, 28. BLBP expression was recently found to be dependent on this pathway25, 26, where
a binding site for the Notch effecter CBF1 was found in the promoter region of BLBP29.

Interestingly, Notch-1 activation has been known for its role in promoting both phenotypes, the
formation of the radial glial cells and their transformation into astrocytes. However, Notch-1
activation has been shown to induce radial glial cells differentiation prenatally and to induce
astrocytic differentiation postnatally31,

32

. Therefore, the presence of other signaling pathways

that act to induce the radial glial phenotype prenatally but are deactivated or downregulated
postnatally seems to be an attractive model to explain how Notch-1 activation leads to different
cellular fates at different developmental stages.

6

Amyloid Precursor Protein and Neurogenesis
β- Amyloid precursor protein (APP) is the precursor of amyloid β peptide (Aβ), which is
associated with the pathogenesis of Alzheimer’s disease (AD), a progressive neurodegenerative
disease33. During its trafficking, APP is subjected to processing by proteolytic enzymes that are
distributed throughout the secretory and the endocytic pathways to generate different APP
fragments34,

35

, which in turn regulate several neural functions including cell excitability,

synaptic transmission and long-term potentiation36.

Processing of APP is initiated via the proteolytic activities of α- and β-secretases, which cleave
APP ectodomain close to its transmembrane domain to liberate soluble APP extracellular
fragments (α- or β-secreted APP respectively). APP cleavage by α- or β-secretases is a key
regulatory process in the generation of the Aβ. After the initial cleavage of APP by α- and/or βsecretase, the remaining membrane-tethered C-terminal APP fragments (CTFs), are further
cleaved within its transmembrane domain by a multimeric protein complex termed γ-secretase to
generate p3 and Aβ respectively, and a cytosolic APP intracellular domain (AICD)33-36.

APP processing is regulated by proteins that bind its intracellular domain, particularly its
YENPTY motif. This motif contains the consensus sequence for the clatherin-coated pit
internalization37,

38

. Dab-1, an adaptor protein that has the phosphotyrosine-binding (PTB)

domain, was found to bind and regulate APP metabolism37, 38.
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In our previous work, we found that the secreted APP (sAPP) can induce the glial differentiation
of human Neural Stem Cells (hNSCs)

39

. In addition, a recent study found that sAPP binds to

cells that express the epidermal growth factor (EGF) receptor in the subventricular zone resulting
in increased proliferation of these neuronal progenitors40. It seems that the level of the sAPP is a
determining factor in the differentiation of the stem cells39, 40. In chapter four, we will briefly
explore the effects of Dab-1 overexpression on the metabolism and processing of APP to lay the
grounds for further investigations of the role of APP metabolism in neurogenesis.
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Rationale and Aims

Radial glial cells do not only guide the migration of neurons from the ventricular zone to the
post-mitotic areas, but they also give rise to these neurons via their asymmetric division during
brain development1-9. The dual roles of the radial glia in regulating the migration and the
generation of the neurons during development suggest that there is an overlap in the signaling
pathways that control these two roles.

Since the end of neurogenesis in the human brain is marked by the transformation of the radial
glial cells into astrocytes4 and since this event coincides with the reduction of Reelin expression
in the cortex41,

42

, then we hypothesized that Reelin signaling prenatally enhances Notch-1

activation and induces the formation of the radial glial cells from the neural progenitors. The
down-regulation of Reelin expression postnatally is therefore expected to allow the
transformation of the radial glial cells into astrocytes. Supporting that, a recent study showed that
adult reeler mice have increased differentiation of the newly generated cells into astrocytes and
decreased differentiation into neurons22.

Our challenge is to determine if the addition of Reelin to neural progenitors that lack Reelin
expression and are entering their gliogenic phase can reverse their fate to regain the neurogenic
phenotype.

Our long term objective is to understand the mechanisms that regulate and enhance neurogenesis
in order to manipulate them to restore brain functions in the adult brain after injury or in
9

neurodegenerative diseases. Our objectives are to confirm the effect of Reelin signaling on
neurogenesis and to elucidate the mechanisms by which this pathway promotes the neuronal fate.
The aims of this study are:

Aim I: Confirm that the activation of Reelin signaling increases the neuronal differentiation of
human Neural Progenitor Cells (hNPCs).
Aim II: Determine if Reelin signaling increases neurogenesis via Notch-1 activation.
Aim III: Investigate the mechanism by which Reelin signaling activates Notch-1.
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Figure 2: A schematic diagram that demonstrates the proposed cross-talk between Reelin
and Notch-1 signaling pathways.
Upon Notch-1 activation, the released NICD translocates to the nucleus and induces BLBP
expression. Reelin signaling is known to induce BLBP expression by unidentified mechanism.
We propose a crosstalk between the two pathways and suggest that Reelin signaling increases
NICD levels to induce BLBP expression and the subsequent formation of neurogenic radial glia.
SFK; Src family kinases, NICD; Notch intracellular domain, BLBP; brain lipid binding protein,
Dab-1; Disabled-1, VLDLR; very low density lipoprotein, ApoER2; ApoE receptor 2.
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CHAPTER TWO:
REELIN INDUCES A RADIAL GLIAL PHENOTYPE IN HUMAN
NEURAL PROGENITOR CELLS BY ACTIVATION OF NOTCH-1

Introduction

Radial glial cells have been recently demonstrated to be the progenitors for the majority of the
central nervous system (CNS) neurons2, 3. They arise early in the development of the CNS from
the neuroepithelial cells that line the ventricles4. Radial glial cells extend a long radial process to
the pial surface while having their cell bodies in the ventricular zone (VZ), allowing the
migration of neurons from the VZ to the post-mitotic areas5. However, the finding that these
cells can also give birth to the migratory neurons via their asymmetric division 6,

7

further

highlighted the significance of these cells in brain development. Interestingly, radial glial cells
disappear or transform into astrocytes in most regions of the mammalian brain after neuronal
generation and migration are completed4.

Brain lipid binding protein (BLBP) is a hydrophobic ligand binding protein that is expressed
throughout the CNS in radial glia and astrocytes during development9. A recent elegant study
using Cre/loxP fate mapping, showed that all neuronal population in the mouse brain are derived
from radial glial cells expressing BLBP3.

Recently, BLBP expression in cortical radial glia as well as its role in radial process extension
was found to be dependent on Reelin expression11. Reelin is a large secreted glycoprotein, which
has been shown to be an important signal for neuronal migration and proper positioning of
12

neurons in the cerebral cortex and cerebellum12. Reelin signal is transmitted into the cells by
Disabled-1 (Dab-1), a cytoplasmic adaptor protein that binds the internalization (NPXY) motif of
the Reelin receptors, apolipoprotein receptor2 (ApoER2) and the very low density lipoprotein
receptor (VLDLR), via its phospho-tyrosine binding (PTB) domain14. The tyrosine
phosphorylation of Dab-1 is initiated after Reelin binds to its receptors15. This phosphorylation
creates new binding sites for Src kinases leading to their activation16,

17

. Mice deficient in,

VLDLR and ApoER2, Dab-1 or Dab-1 that cannot be tyrosine phosphorylated generates a reelerlike phenotype, which is characterized by inversion of the cortical layers and abnormalities in the
laminated brain structures18.

Reelin effect on BLBP expression requires Dab-1 as well, as it failed to occur in Dab-1–/–
mice11. Reeler and Dab-1 mutant mice were shown to exhibit abnormal development of the
radial glia scaffold in the dentate gyrus of the hippocampus19. Furthermore, components of the
Reelin signaling pathway, including VLDLR, ApoER2, and Dab1 were shown to be expressed in
both the hippocampal and cortical radial glia19, 20. Interestingly, Reelin addition in-vitro has been
shown not only to promote the process extension of the radial glial cells but also to rescue the
defects in the length of these processes in the reeler mutant radial glia11.

A recent study showed that Notch-1 signaling could also regulate the molecular and the
morphological differentiation of radial glia through the transcriptional activation of brain lipid
binding protein (BLBP)

25, 26

. Notch is a single-pass transmembrane protein that was initially

identified in Drosophila and has been shown to mediate many developmental signaling events24.
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Notch-1 activation, upon binding its ligand, will initiate its cleavage by -secretase to generate
Notch-1 intracellular domain (NICD). NICD translocates to the nucleus and binds C-promoter
Binding Factor 1 (CBF1), converting it from transcriptional repressor to transcriptional
activator27, 28. Interestingly, BLBP expression was found to be dependent on this pathway25, 26,
where a binding site for the Notch-1 effecter’s CBF1 was found in the promoter region of
BLBP29.

Since Notch-1 activation can induce the formation of radial glial cells prenatally and their
transformation into astrocytes postnatally31, 32, we hypothesized that Reelin signaling may act to
fine-tune Notch-1 activation to favor the induction of the radial glial phenotype prenatally. This
in turn can explain how the degeneration of the cells that produces Reelin in the cortex coincides
with transformation of the radial glial cells into astrocytes postnatally41, 42. In our study, in vitro
addition of Reelin to human Neural Progenitor Cells (hNPCs), isolated from the cortex of 14
weeks old fetus, induced BLBP expression and a radial glial phenotype similar to that induced by
Notch-1 activation. The inhibition of Notch-1 activation by inhibiting the activity of γ-secretase
abolished Reelin’s effect, suggesting the dependency of Reelin signaling on Notch-1 activation.
Furthermore, Reelin treatment increased the level of NICD, indicating that Reelin can directly
activate Notch-1. Finally, Dab-1 was observed to bind to Notch-1, thus providing an evidence of
the physical interaction between these two pathways.

14

Materials and Methods

Cell Culture

We used ReNcell CX (Chemicon), an immortalized human Neural Progenitor Cell (hNPC) line.
These cells were isolated from the cortex of a 14-weeks human fetal brain and immortalized by
retroviral transduction with the c-myc oncogene. The cells were cultured in ReNcell NSC
maintenance media (Chemicon) supplemented with 20ng/ml of the fibroblast growth factor
(FGF) and 20ng/ml and of the epidermal growth factor (EGF) (Chemicon). These cells can
differentiate into neurons and glial cells.

The cells were deprived of the growth factors, FGF and EGF, for 24 hours before Reelin
treatment or NICD overexpression to exclude the effects of these factors on the induced radial
glial phenotype.

For transfection of hNPCs, the cells were plated on laminin coated (Sigma Aldrich) 12-well
culture plates (BD biosciences) for 24 hours or until they reached 90% confluency. The cells
were then transiently transfected with 2-µg of DNA/well using lipofectamine LTX and Plus
reagents according to manufacturer’s instructions (Invitrogen). The transfection efficiency was
determined by finding the percentage of the GFP fluorescent cells 24 hours after transfecting the
hNPCs with EGFP vector (Invitrogen). The transfection efficiency was optimized by transfecting
the cells with different ratios of DNA/PLUS/LTX, where the best transfection efficiency was
found to be 30-40%, using the ratio of 1/3/3, respectively.
15

For -secretase inhibition, 10 M of -secretase inhibitor (L-685, 458; Sigma Aldrich) or 0.1% of
Dimethysulfoxide (DMSO; Sigma Aldrich) as control, were prepared in growth media and added
to the cells.

Dab-1 gene (Accession # NM_021080) was cloned into pcDNA3.1 vector with FLAG tag on its
C terminus (Invitrogen); sequencing was performed to assure that the clone is in frame. FCDN1
expressed in pBOS-EF1 (1747-2531 aa) was kindly provided by Dr. Gerry Weinmaster, UCLA.

Reelin Production and Treatment

Reelin- and control-containing media was collected from HEK293 cells stably transfected with
RELIN pCRL vector (kindly provided by T. Curran, St. Jude Children’s Hospital, Memphis
Tennessee, USA), and a control empty pcDNA3.1 vector (Invitrogen), respectively19, 43, 44. The
cells were cultured in neurobasal media (Invitrogen) for 3 days before media collection. Reelin
was partially purified using columns with filters >100kDa (Chemicon) and Reelin levels were
confirmed by western blotting using anti-Reelin clone G10 (Chemicon) that detected the three
characteristic bands of Reelin (400 KDa, 300 KDa, and 180 KDa) 15.
The control- or Reelin-conditioned media that were used to treat the hNPCs were prepared by
diluting the purified control or Reelin in ReNcell CX maintenance media at a final concentration
of 1:40. This concentration was determined by finding the lowest concentration of Reelin that
can induce Dab-1 tyrosine phosphorylation as early as 15 minutes.
.
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Protein Isolation and Western Blot Analysis

The hNPCs were lysed in ice-cold RIPA (Radio-Immunoprecipitation Assay) lysis buffer (Sigma
Aldrich) containing 150 mM NaCl, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1%
SDS, and 50 mM Tris, pH 8.0, supplemented with 1% Triton-X and protease inhibitor mixture
(Calbiochem). The homogenates were centrifuged at 12,000 x g for 30 min at 4ºC and the
supernatants were saved for analysis. 40 µg of proteins were loaded per well. The proteins were
then separated by SDS/PAGE (NuPage 4%-12% Bis-Tris, Invitrogen) for 60 min at 200 V, and
then blotted onto polyvinyldiene difluride (PVDF) membranes (Bio-rad) for 120 min at 30 V.
For the detection of full-length Notch-1, activated Notch-1, Reelin, BLBP, β-actin, Dab-1 and
pY198Dab-1, membranes were incubated overnight with following primary antibodies,
respectively: mouse anti-Notch-1 (1:1,000; Sigma Aldrich), rabbit anti-activated Notch-1 (1:500;
Abcam), mouse anti-Reelin clone G10 (1:1000; Chemicon), rabbit anti-BLBP (1:500; Abcam),
rabbit anti

-actin (1:1,000; Cell Signaling Technology), rabbit anti-Dab-1 (1:1000; Sigma

Aldrich) and rabbit anti-Dab-1 phospho tyrosine 198 (1:1000; Chemicon). After washing the
membranes they were incubated with horseradish peroxidase-conjugated secondary antibodies at
concentration of 1:5000 (anti-mouse IgG and anti-rabbit IgG; Jackson Immunoresearch, West
Grove, PA) for 1–2 h. Signals were detected by chemiluminescence using the enhanced
chemiluminescence (ECL) system (Amersham Biosciences Corp) on a Kodak Imaging Station
IS2000MM. The optical density of each specific band relative to β-actin was analyzed by the
public domain National Institutes of Health Image J software.
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Immunoprecipitation

700µg of proteins were incubated for 3 hours at 4°C with the primary antibody anti-Notch-1
(1:100; Sigma Aldrich), or anti-Flag (1:200; Sigma Aldrich), or anti-NICD (1:500; Abcam),
Protein G- or A-Sepharose beads were added for 1 hr at 4°C, and then immunoprecipitates were
washed 5X with lysis buffer. Immunoprecipitated proteins were solubilized in 1% SDS solution
and resolved on a 4-12% Bis-Tris gel (Invitrogen).

Fluorescent Immunocytochemistry

The hNPCs were fixed with 4% Paraformylaldehyde (Sigma Aldrich) overnight at 4ºC. The next
day, the cells were washed three times with phosphate buffered saline (PBS-Sigma Aldrich) at
room temperature and blocked with 3% donkey serum (Jackson ImmunoResearch Labs) in
phosphate buffered saline with 0.1% Triton-X (PBST- Sigma Aldrich) for 1 hour at room
temperature. For analyzing the radial glial phenotypes, hNPCs were incubated with rabbit antiBLBP (1:50; Abcam) and mouse anti- GFAP (1:500; Sigma Aldrich) for 24 hrs at 4º C. After
washing the cells with PBS for three times the cells were incubated with Tetramethyl Rhodamine
Iso-Thiocyanate (TRITC)-conjugated anti-rabbit and Fluorescein isothiocyanate (FITC)conjugated anti-mouse (1: 500; Jackson ImmunoResearch Labs) for 2 hrs at room temperature in
the dark. The cells were washed again and mounted with vectasheild with DAPI (vector
laboratories) and cover slipped for microscopic observations.
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Microscopy and Analysis

The induced radial glial phenotype was calculated by finding the percentage of the GFAP
positive cells that had an induced BLBP expression45 and a bipolar morphology, with at least one
thin process longer than 50 µm. This criterion was based on previous studies11,

46

. Adobe

Photoshop CS3 software was used to count the number of cells. Microscopic images were taken
with the QImaging MicroPublisher 5.0 color digital imaging system and processed using the
QCapture software (Leeds, Irving, TX).

Statistical Analysis

Each data point represents triplicated experiments and displayed as the mean ± standard error. A
one-way Analysis of Variance was performed to test the hypothesis that the average mean values
across categories of GROUP were equal. In the presence of significance for the omnibus
ANOVA test, Tukey multiple comparison test is used to perform pairwise comparisons. Statistics
were performed using WINKS SDA Software (Texasoft, Cedar Hill, TX.).

Results

Reelin Treatment of hNPCs Induces a Radial Glial Phenotype
Radial glial cells transform into astrocytes postnatally4, an event that coincides with the
degeneration of the layer that produces Reelin in the cortex 41,
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. In addition, a recent study

showed that adult reeler mice have increased differentiation of the newly generated cells into
astrocytes and decreased differentiation into neurons22.

In order to investigate the role of Reelin on the formation of radial glia, we used human Neural
Progenitor Cells (hNPCs) that were isolated from the cortex of a 14 weeks old fetus and
immortalized in-vitro. In culture, these cells appear as a pure culture of glial fibrillary acidic
protein (GFAP) positive cells with long radial processes (Figure 3, a).

FGF and EGF pathways are known to promote the formation of radial glia48, 49. To exclude the
effects of FGF and EGF on the formation of radial glia, we deprived the hNPCs of these growth
factors for 24 hours before treating the cells with Reelin. As expected, the deprivation of these
growth factors reduced the radial glial phenotype, which was characterized by the retraction of
the radial processes in the GFAP positive cells (Figure 3, b).
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+FGF+EGF
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Anti-GFAP

a

Figure 3: The formation of radial glia in hNPCs is dependent on the growth factors FGF
and EGF.
The deprivation of the growth factors FGF and EGF for 24 hours results in the retraction of the
radial processes in the GFAP positive cells (red). Scale bar is 100 µm.
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In order to characterize the effects of Reelin on the hNPCs, we treated the hNPCs with Reelin for
24 hours. Control- and Reelin-containing media were collected from HEK293 cells transfected
with either control empty vector or Reelin, respectively. Reelin was partially purified (P.P) from
the medium by column centrifugation and its expression was verified by western blotting using
anti-Reelin clone G10 (Figure 4). The cells were treated with control or Reelin-conditioned
media that was prepared by diluting the purified control or Reelin in the maintenance media at a
final concentration of 1:40.

As a result, Reelin treatment was observed to re-induce the formation radial glia from the hNPCs
that has been deprived of FGF and EGF. The newly formed radial glia was characterized by
increased radial process extension in the GFAP positive cells (Figure 5).
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Control medium
Reelin medium

Control medium
Reelin medium

P. P

400KDa
300KDa
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180KDa

Figure 4: Reelin levels in the media of HEK293 cells that are stably transfected with Reelin.
Control and Reelin-containing media were collected from HEK293 cells transfected with either
an empty vector or Reelin, respectively. Reelin was partially purified (P.P) from the medium by
column centrifugation and its expression was verified by western blotting using anti-Reelin clone
G10.
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Figure 5: Reelin treatment in vitro induces a radial glial phenotype.
The hNPCs were deprived of FGF and EGF for 24 hours and treated with control or Reelinconditioned media for another 24 hours before fixation. The cells were later stained against
GFAP. Scale bar is 200 µm.
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To confirm that Reelin signaling is induced after Reelin treatment, the hNPCs were treated with
control- or Reelin-conditioned media for 0, 15, 30 or 60 minutes. The conditioned media was
prepared by diluting the purified control or Reelin in ReNcell CX maintenance media at a final
concentration of 1:40. The induction of Reelin signaling was determined by measuring the level
of Dab-1 phosphorylation on the tyrosine residue 198. As a result, we found that Dab-1 tyrosine
phosphorylation increased with time after Reelin treatment, whereas it remained constant with
the control treatment (Figure 6).

25

Control-medium
Reelin-medium

+ + + +
- - - 0 15 30 60

- - - + + + +
0 15 30 60 (mins)

80KDa

Dab1-p-Y198

80KDa

Dab1

Figure 6: Reelin treatment of hNPCs induces Dab-1 phosphorylation on tyrosine residue
198.
The hNPCs were treated with control- or Reelin-conditioned media for 0, 15, 30 or 60 minutes
before cell isolation. Dab-1 phosphorylation was measured by detecting the phosphorylation
level on the tyrosine residue 198.
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Reelin Treatment of hNPCs Induces the Formation of Neurogenic Radial Glia

A recent elegant study using Cre/loxP fate mapping, showed that all neuronal population in the
mouse brain are derived from radial glial cells expressing BLBP3. It’s been suggested that the
induction of BLBP marks the onset of radial glia neurogenesis where BLBP expression in radial
glial cells have been shown to be up-regulated at the onset of neurogenesis and maintained as
neurogenesis proceeds3. BLBP expression in cortical radial glia as well as its role in radial
process extension was recently found to be dependent on Reelin signaling11.

To investigate if the Reelin-induced radial glial cells we observed in (Figure 5) are neurogenic,
we measured the expression of BLBP in the formed radial glia. The hNPCs were deprived of
FGF and EGF for 24 hours and then treated with control- or Reelin- conditioned media for
another 24 hours before fixation. The induced neurogenic radial glia were determined by finding
the percentage of the GFAP positive cells that had induced BLBP expression and a bipolar
morphology with at least one thin process longer than 50 µm11, 46.

As shown in (Figure 7), Reelin treatment up-regulated BLBP expression and induced a bipolar
radial morphology. The percentage of the neurogenic radial glia increased from (3.40±0.04) % in
the control treated cells to (9.48±0.68) % in the Reelin treated cells, *p-value < 0.05.
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Figure 7: Reelin treatment induces neurogenic radial glial cells in hNPCs.
The hNPCs were deprived of FGF and EGF for 24 hours and then treated with either control- or
Reelin-conditioned media for another 24 hours before fixation. The cells were then stained
against GFAP (green) and BLBP (red). The percentage of the BLBP-positive radial glia
increased from (3.40±0.04) % in the control treated cells (a-c) to (9.48±0.68) % in the Reelin
treated cells (d-f), *p-value< 0.05. Arrows point to a GFAP positive cell with induced BLBP
expression and a bipolar morphology. The data points represent the mean ± standard error of at
least three independent experiments. One-way ANOVA followed by Tukey’s post-hoc test was
used for the statistical analysis. Values that are significantly different from each other according
to Tukey's test are indicated by asterisks. Scale bars for a and d is 100 μm and for b, e, c and f is
50 μm.
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The Reelin-induced Radial Glial Phenotype is Dependent on Notch-1 Activation

It has been shown that Notch-1 signaling regulates the molecular and the morphological
differentiation and maturation of radial glia through the transcriptional activation of BLBP25, 26.
To test if Reelin acts on Notch-1 activation to promote the formation of the neurogenic radial
glia, we first compared the induced radial glial phenotype obtained after Reelin treatment and
Notch-1 activation.

NICD overexpression was used to mimic Notch-1 activation. The hNPCs were deprived from
FGF and EGF for 24 hours and were then treated with Reelin or transfected with NICD for
another 24 hours before fixation. The cells were later stained against BLBP and GFAP and the
induced neurogenic radial glia was determined by finding the percentage of the GFAP positive
cells that had induced BLBP expression and a bipolar morphology with at least one thin process
longer than 50 µm11, 46.

As shown in (Figure 8), Reelin treatment and NICD transfection resulted in similar neurogenic
radial glial phenotype. NICD transfection increased the percentage of the BLBP-positive radial
glia from (2.31±0.23) % in the empty vector transfected cells to (6.19±0.28) % in the NICD
transfected cells, *p-value< 0.05. In contrast, Reelin treatment increased their percentage from
(3.40±0.04) % in the control treated cells to (9.48±0.68) % in the Reelin treated cells, **p-value<
0.05.
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Figure 8: Reelin treatment induces a radial glial phenotype similar to Notch-1 activation.
The hNPCs were deprived of FGF and EGF for 24 hours prior to their transfection or treatment.
The cells were later transfected with either the empty vector or NICD for 24 hours before
fixation. The percentage of the BLBP-positive radial glia increased from (2.31±0.23) % in the
empty vector transfected cells (a-c) to (6.19±0.28) % in the NICD transfected cells (d-f), *pvalue< 0.05. In comparison, the percentage of the BLBP-positive radial glia increased from
(3.40±0.04) % in the control treated cells to (9.48±0.68) % in the Reelin treated cells (g-i), **pvalue<0.05. Arrows point to a GFAP positive cell with induced BLBP expression and a bipolar
morphology. The data points represent the mean ± standard error of at least three independent
experiments. One-way ANOVA followed by Tukey’s post-hoc test was used for the statistical
analysis. Values that are significantly different from each other according to Tukey's test are
indicated by asterisks. Scale bar for a, d and g is 100 μm and for b, e, c, f, h and i is 50 μm.
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To test the dependency of Reelin signaling on Notch-1 activation to induce the radial glial
phenotype, we blocked NICD release by inhibiting the activity γ-secretase. The cells were
deprived of FGF and EGF for 24 hours and then treated with either control- or Reelinconditioned media supplemented with 10 µM of the γ-secretase inhibitor (L- 685, 458) for
another 24 hours.

As shown in (Figure 9), the inhibition of γ-secretase activity in the Reelin treated cells reduced
the percentage of the radial glial cells from (9.48±0.68) % to (1.58±0.03) %, ***p-value< 0.05.
These data suggest that Reelin’s role in inducing the radial glial phenotype is dependent on the
activity of γ –secretase.
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Figure 9: The Reelin-induced radial glial phenotype is dependent on γ-secretase activity.
The hNPCs were deprived of FGF and EGF for 24 hours and then treated with control- or
Reelin-conditioned media supplemented with either 0.1% DMSO as a control or 10 µM of the γsecretase inhibitor L-685,458 for another 24 hours. The inhibition of γ-secretase activity in the
Reelin treated cells abolished Reelin’s effect by reducing the percentage of the BLBP-positive
radial glia from (9.48±0.68) % to (1.58±0.03) %, ***p-value<0.05. The data points represent the
mean ± standard error of at least three independent experiments. One-way ANOVA followed by
Tukey’s post-hoc test was used for the statistical analysis. Values that are significantly different
from each other according to Tukey's test are indicated by asterisks. Scale bar for a and d is 100
μm and for b, e, c and f is 50 μm.
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Reelin Treatment Activates Notch-1

To determine if Reelin regulates Notch-1 signaling, we measured the protein levels of NICD
after Reelin treatment using an antibody that can recognize only the activated form of Notch-1
(NICD). The hNPCs were treated with control- or Reelin-conditioned media supplemented with
either 0.1% DMSO or 10 µM of the γ-secretase inhibitor (L, 685, 458) for 24 hours. As shown in
(Figure 10), Reelin treatment increased NICD levels by (1.68±0.07) fold when compared to the
control treated cells (1.00±0.10) fold, *p-value<0.05. In contrast, the inhibition of γ-secretase
activity in the Reelin-treated cells reduced NICD levels back to (1.13±0.02) fold, **p-value<
0.05.
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Figure 10: Reelin treatment activates Notch-1.
The hNPCs were treated with control- or Reelin-conditioned media supplemented with either
0.1% DMSO or 10µM of the γ-secretase inhibitor (L, 685, 458) for 24 hours. Reelin addition in
vitro increased the accumulation of NICD by (1.68±0.07) fold when compared to the control
treated hNPCs (1.00±0.10) fold, * p-value<0.05. The inhibition of γ-secretase activity abolished
this increase and reduced NICD levels back to (1.13±0.02) fold, ** p-value<0.05. The data
points represent the mean ± standard error of at least three independent experiments. One-way
ANOVA followed by Tukey’s post-hoc test was used for the statistical analysis. Values that are
significantly different from each other according to Tukey's test are indicated by asterisks.
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Reelin Increases Dab-1 Binding to Notch-1

Next we tested if Dab-1 binds to Notch-1 and if Reelin can increase the binding of Dab-1 to
Notch-1. The hNPCs were treated with control- or Reelin-conditioned media for 15 minutes at
4°C to allow Reelin binding the cell surface. The unbound Reelin was then washed away with
PBS and the cells were incubated for 15 minutes at 37 °C before isolation.

An immunoprecipitation using an antibody recognizing Notch-1 co-immunprecipitated Dab-1 in
both the control and the Reelin treated cells (Figure 11-a). Similarly, an immunoprecipitation
using an antibody against Dab-1 was able to co-immunoprecipitate full-length Notch-1 in both
the control and the Reelin treated cells (Figure 11-b). In both cases, Reelin treatment increased
the binding of Dab-1 to Notch-1.
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Figure 11: Reelin increases the binding of Dab-1 to Notch-1.
The hNPCs were treated with control- or Reelin-conditioned media for 15 minutes at 4°C to
allow Reelin binding the cell surface. The unbound Reelin was then washed away with PBS and
the cells were incubated for 15 minutes at 37 °C before isolation. Western blots showing
reciprocal co-immunoprecipitation (IP). (a) Co-immunoprecipitation of Dab-1 by Notch-1 (b)
Co-immunoprecipitation of Notch-1 by Dab-1.
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Discussion

Reelin and Notch-1 signaling pathways have been recently found to be necessary to induce the
expression of BLBP and to promote the process extension and the maturation of the neuronal
progenitors, the radial glial cells11, 25, 26, 29.

The end of neurogenesis in the cortex is marked by the transformation of the radial glial cells
into astrocytes4. Notch-1 activation has been known for its role in promoting both phenotypes,
the formation of the radial glial cells and their transformation into astrocytes. Interestingly,
Notch-1 activation has been shown to induce radial glial cells differentiation prenatally and to
induce astrocytic differentiation postnatally31,
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. Therefore, the presence of other signaling

pathways that act to induce the radial glial phenotype prenatally but are deactivated or
downregulated postnatally seems to be an attractive model to explain how Notch-1 activation
leads to different cellular fates at different developmental stages.

Reelin signaling has been recently shown to induce the radial glial phenotype in vitro and to
rescue the defects in the reeler mutant radial glia11. Interestingly, Cajal-Retzius cells, the cells
that produce Reelin in the cortical marginal zone, are thought to either degenerate postnatally41
or undergo developmental dilution42.

Here, we propose that Reelin signaling promotes Notch-1 activation to favor the radial glial
phenotype prenatally. To test our hypothesis, we used human neural progenitor cells that were
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isolated from the cortex of 14 weeks fetus. We show that these cells responded to Reelin
treatment by inducing a bipolar morphology in the GFAP positive cell indicating the formation
of radial glia (Figure 7). Since this Reelin-induced phenotype was dependent on γ-secretase
activity (Figure 9), and since Reelin treatment increased the protein levels of NICD (Figure 10),
then we concluded that Reelin signaling promotes the radial glial phenotype by activating
Notch1.

Reelin signaling might regulate Notch-1 activation via increasing Dab-1 binding to Notch-1
(Figure 11). It’s possible that Reelin signaling mediated by Dab-1 increases the NICD protein
levels by either increasing Notch-1 processing by γ -secretase or by stabilizing the released
NICD. Since Dab-1 has been recently shown to act as a nucleocytoplasmic shuttling protein50,
Dab-1 may in turn mediate the translocation of NICD into the nucleus to activate downstream
genes such as BLBP. However, the exact mechanism needs further elucidation.

Taken together, this study offers a new insight of how Reelin and Notch-1 signaling are
determining that fate of the neural progenitor cells and maintaining the radial glial phenotype in
the developing brain.
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CHAPTER THREE:
REELIN ACTIVATES NOTCH-1 SIGNALING THROUGH DISABLED-1
TYROSINE PHOSPHORYLATION
Introduction

Reelin is a large secreted glycoprotein that has been shown to be an important signal for neuronal
migration and proper positioning of neurons in the cerebral cortex and cerebellum12. Reelin
signal is transmitted into the cells after Reelin binds its receptors, apolipoprotein receptor2
(ApoER2) and the very low density lipoprotein receptor (VLDLR). Reelin binding initiates
Disabled-1 (Dab-1) binding to the internalization (NPXY) motif of ApoER2 and VLDLR,
leading to the induction of Dab1 tyrosine phosphorylation14. Tyrosine phosphorylation of Dab-1
creates new binding sites for Src kinases and results in the activation of phosphoinositide-3Kinase (P13-K)-dependent kinase and Akt15-17. Mice deficient in VLDLR and ApoER2, Dab1 or
Dab1 that cannot be tyrosine phosphorylated generates a reeler-like phenotype, which is
characterized by inversion of the cortical layers and abnormalities in the laminated brain
structures18.

Recently, reeler mice were shown to exhibit abnormal development of the radial glial scaffold in
the dentate gyrus of the hippocampus19. Radial glia, as their name indicates, extend a long radial
process to the pial surface while having their cell bodies in the ventricular zone (VZ) thus
allowing the migration of neurons from the VZ to the post-mitotic areas5. However, the finding
that these cells can also give birth to the migratory neurons, via their asymmetric division6, 7,
further highlighted the significance of these cells in brain development. Interestingly, radial glial
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cells disappear or transform into astrocytes in most regions of the mammalian brain after
neuronal generation and migration are completed4.

A recent study showed that Notch-1 signaling regulates the molecular and the morphological
differentiation of radial glia through the transcriptional activation of brain lipid binding protein
(BLBP) 25, 26. Notch activation, upon binding its ligand, will initiate its cleavage by -secretase to
generate Notch intracellular domain (NICD). NICD translocates to the nucleus and binds Cpromoter Binding Factor 1 (CBF1), converting it from transcriptional repressor to transcriptional
activator27, 28. Interestingly, BLBP expression was found to be dependent on this pathway25, 26,
where a binding site for the Notch effecter CBF1 was found in the promoter region of BLBP29.
BLBP expression in cortical radial glia as well as its role in radial process extension was also
found to be dependent on Reelin signaling11.

In our previous work (Chapter two), we found that Reelin addition to the hNPCs induced BLBP
expression and increased the formation of radial glia. The Reelin-induced radial glial cells were
shown to be dependent on Notch-1 activation. We found that Reelin activates Notch-1 signaling
by increasing the level of Notch-1 intracellular domain (NICD). Reducing NICD levels, by
inhibiting γ -secretase activity, inhibited the Reelin-induced radial glia. These data indicated that
Reelin induces BLBP expression and the formation of radial glia via activating Notch-151.

Here, we investigated the molecular mechanisms by which Reelin activates Notch-1. We found
that the Reelin-induced tyrosine phosphorylation of Dab-1 and the subsequent activation of Src
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family kinases are essential steps for Notch-1 activation by Reelin. In addition, Reelin treatment
increased Dab-1 binding to NICD and enhanced NICD translocation to the nucleus to induce the
expression of BLBP. Reelin treatment did not enhance γ-secretase processing of Notch-1,
suggesting that Reelin increases NICD levels by an alternative mechanism. Finally, Reelin
treatment significantly enhanced neurogenesis in hNPCs in vitro.

Materials and Methods

Cell Culture

We used ReNcell CX (Chemicon), an immortalized human neural progenitor cell line (hNPCs).
The cells were cultured in ReNcell NSC maintenance media (Chemicon) supplemented with
20ng/ml of the fibroblast growth factor (FGF) and 20ng/ml and of the epidermal growth factor
(EGF) (Chemicon).

For transfection of hNPCs, the cells were plated on laminin coated (Sigma Aldrich) 12-well
culture plates (BD biosciences) for 24 hours or until they reached 90% confluency. The cells
were then transiently transfected with 2 µg of DNA/well using lipofectamine LTX and PLUS
reagents according to manufacturer’s protocol (Invitrogen). The transfection efficiency was
determined by finding the percentage of the Green Fluorescent Protein (GFP) positive cells 24
hours after transfecting the hNPCs with EGFP vector (Invitrogen). The transfection efficiency
was optimized by transfecting the cells with different ratios of DNA/PLUS/lipofectamine, where
the best transfection efficiency was found to be 30-40%, using the ratio of 1/3/3, respectively.
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For γ-secretase inhibition, 10 μM of the γ-secretase inhibitor (L-685, 458; Sigma Aldrich) was
dissolved in the maintenance media. For the control cells, we added the maintenance media
containing 0.1% DMSO.

To inhibit cell endocytosis, we treated hNPCs with a hypertonic sucrose solution (0.5M) 52. The
cells were first treated with control- or Reelin-conditioned media for 15 minutes at 4°C. The
unbound Reelin was washed away with PBS and the cells were incubated with 0.5M sucrose
prepared in cell media for 30 minutes at 37˚C.

To inhibit Src activity, hNPCs were pre-treated with 10 µM of the Src inhibitor PP2 for 1 hour at
37°C 52. As a control, hNPCs were pre-treated with 10 µM of PP3 (inactive analog of PP2). The
cells were later treated with either control- or Reelin-conditioned media for 1 hour in the
presence of PP2 or PP3.

pDsDab1RFP (wild-type mouse Dab1-RFP fusion protein) and pDsDab1RFP-5F (a Dab1 mutant
with five tyrosines mutated to phenylalanines) clones
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were kindly provided by Dr. Brian W.

Howell, Neurogenetics Branch, National Institute of Neurological Diseases and Stroke, National
Institutes of Health, Bethesda, Maryland.
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Reelin Production and Treatment

Reelin- and control-containing media were collected from HEK293 cells stably transfected with
RELIN pCRL vector (kindly provided by T. Curran, St. Jude Children’s Hospital, Memphis
Tennessee, USA), and a control empty pcDNA3.1 vector (Invitrogen), respectively19, 43, 44. The
cells were cultured in neurobasal media (Invitrogen) for 3 days before media collection. Reelin
was partially purified using columns with filters >100kDa (Chemicon) and Reelin level was
estimated by Western blotting using anti-Reelin clone G10 (Chemicon) that detected the three
characteristic bands of Reelin (400 KDa, 300 KDa, and 180 KDa) 15.

The conditioned media that was used to treat hNPCs was prepared by diluting the purified Reelin
in ReNcell CX maintenance media at a final concentration of 1:40. This concentration was
determined by finding the lowest concentration of Reelin that can induce Dab-1 phosphorylation
as early as 15 minutes.

The hNPCs were also co-cultured with HEK293 cells that stably express Reelin using millicell
culture inserts (Millipore). The hNPCs were plated at the bottom of the 6-well plates while the
HEK293 cells were plated in the insert. The cells were deprived of FGF and EGF and the media
for both cell lines was partially changed (50%) every day. Reelin expression in Hek293 cells and
in its passage through the insert’s membrane was confirmed by detecting the levels of Reelin in
the media of the co-cultured HEK293 cells and hNPCs using western blotting.
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Protein Isolation and Western Blot Analysis

The hNPCs were lysed in ice-cold RIPA (Radio-Immunoprecipitation Assay) lysis buffer (Sigma
Aldrich) containing 150 mM NaCl, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1%
SDS, and 50 mM Tris, pH 8.0, supplemented with 1% Triton-X and protease inhibitor mixture
(Calbiochem). The cell lysates were centrifuged at 12,000 xg for 30 min at 4˚C and the
supernatants were saved for analysis. Proteins (40µg/well) were separated by SDSPolyacrylamide gel electrophoresis (NuPage 4%-12% Bis-Tris gel, Invitrogen) for 60 min at 200
V, and then blotted onto polyvinyldiene difluride (PVDF) membranes (Bio-rad) for 120 min at
30 V. For the detection of full-length Notch-1, NICD, Reelin, β-actin, Dab-1 and pY198Dab-1,
the PVDF membranes were incubated overnight with following primary antibodies, respectively:
mouse anti-Notch-1 (1:1,000; Sigma Aldrich), rabbit anti-activated Notch-1 (1:500; Abcam),
mouse anti-Reelin clone 142 (1:1000; Chemicon), rabbit anti-β-actin (1:1,000; Cell Signaling
Technology, Danvers, MA), rabbit anti-Dab1 (1:1000; Abcam) and rabbit anti-Dab1 phospho
tyrosine 198 (1:1000; Abcam). After washing the membranes with phosphate buffered saline
with Tween 20 (PBST- Sigma Aldrich), the membranes were incubated with the appropriate
horseradish peroxidase-conjugated secondary antibodies at concentration of 1:5000 (anti-mouse
IgG or anti-rabbit IgG; Jackson Immunoresearch, West Grove, PA) for 2 hrs. Immunoreactivities
were detected by chemiluminescence using the enhanced chemiluminescence (ECL) system
(Amersham Biosciences Corp) on a Kodak Imaging Station IS2000MM. The optical density of
each specific band relative to β-actin was analyzed by Image J software (National Institutes of
Health).
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For nuclear extraction, the plated hNPCs were lysed using a subcellular fractionation buffer (
250 mM Sucrose, 20 mM HEPES (pH 7.4), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, supplemented with protease inhibitor mixture (Calbiochem)). The nuclear
pellet (P1) was centrifuged out at 3000 rpm for 5 minutes and then washed once by adding 500µl
of the fractionation buffer. The nuclear pellet was centrifuged again at 3000 rpm for 10 minutes
and the pellet was resuspended in the nuclear buffer (RIPA with 10% glycerol and 0.1% SDS).
The pellet was then sonicated briefly for 3 seconds at a power setting of 2-continous. Finally, the
nuclear pellet was centrifuged at 16,000 xg for 30 minutes and the final supernatant was used for
analysis.

Immunoprecipitation

The hNPCs were lysed in ice-cold RIPA (Radio-Immunoprecipitation Assay) lysis buffer (Sigma
Aldrich) containing 150 mM NaCl, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1%
SDS, and 50 mM Tris, pH 8.0, supplemented with 1% Triton-X and protease inhibitor mixture
(Calbiochem). 700µg proteins were incubated for 3 hours at 4°C with the primary antibody antiDab1 (1:100; Abcam) or anti-NICD (1:500; Abcam). Protein A-Sepharose beads were added for
1 hr at 4°C, and then immunoprecipitates were washed 5 times with RIPA lysis buffer.
Immunoprecipitated proteins were solubilized in sample buffer containing 1% SDS and resolved
on a 4-12% Bis-Tris gel (Invitrogen).
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Fluorescent Immunocytochemistry

The hNPCs were plated on laminin coated (Sigma Aldrich) 8-wells-chambers slides (BD
biosciences) for 24 hours. After treatment, hNPCs were fixed with 4% Paraformylaldehyde
(Sigma Aldrich) overnight at 4ºC. Then, the cells were washed three times with phosphate
buffered saline (PBS- Sigma Aldrich) at room temperature and blocked with 3% donkey serum
(Jackson ImmunoResearch Labs) in phosphate buffered saline with Tween 20 (PBST- Sigma
Aldrich) for 1 hour at room temperature. The hNPCs were incubated for 24 hrs at 4° C, with the
following primary antibodies: rabbit anti-Nestin (1:200; Millipore) with Goat anti-Doublecortin
(C-18) (1:50; Santa Cruz biotech); rabbit anti-BLBP (1:50; Abcam) with mouse anti-Notch-1
(1:500; Sigma Aldrich), rabbit anti- Notch-1 (1:500; cell signaling) or rabbit anti-VLDLR (H-95)
(1:500; Santa Cruz Biotech) with mouse anti-Reelin clone 142 (1:1000; Chemicon). After
washing the cells with PBS for three times the cells were incubated with Tetramethyl Rhodamine
Iso-Thiocyanate (TRTIC)-conjugated or Fluorescein isothiocyanate (FITC)-conjugated antimouse or anti-rabbit or anti-goat (1: 500; Jackson ImmunoResearch Labs) for 2 hrs at room
temperature in the dark. The cells were washed again and mounted with vectasheild with DAPI
(vector laboratories) and cover slipped for microscopic observations.

Microscopy and Analysis

The percentage of radial glial phenotype in a culture was calculated by counting the number of
the Nestin positive cells that had a bipolar morphology with at least one thin process longer than
50 µm against the total number of cells. This criterion was based on previous studies11, 46. Adobe
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Photoshop CS3 software was used to count the number of cells. Microscopic images were taken
with the QImaging MicroPublisher 5.0 color digital imaging system and processed using the
QCapture software (Leeds, Irving, TX).

In-vitro γ-secretase Assay
To measure γ-secretase activity after Reelin treatment, hNPCs were treated with either controlor Reelin-conditioned medium for 12 hours. As a positive control, hNPCs were treated with
either 10 µM of the γ-secretase inhibitor L-685,458 or 0.1% DMSO for 12 hours. The γ-secretase
activity was measured using a γ-secretase activity kit according to manufacturer’s protocol (R &
D systems). The treated hNPCs were extracted using the extraction buffer provided with the kit.
The assay was set-up in triplicates. In short, 50 μL of cell lysate (i.e. derived from approximately
2 - 5 x 106 cells or 25 - 200 μg of total protein), 50 μL of 2X Reaction Buffer and 5 μL of
Substrate were added to each well of a microplate. The plate was incubated in the dark at 37°C
for 2 hours. The plate was read on a fluorescent microplate reader using light filters that allow
for the excitation of the reporter molecule EDANS at 355 nm wavelengths. Emission was
measured at 510 nm. As a negative control, the reactions were prepared without the cell lysate.
The results were expressed as the percent of increase of fluorescence over that of the negative
control.
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Statistical Analysis

Each data point represents triplicated experiments and displayed as the mean ± standard error. A
one-way Analysis of Variance was performed to test the hypothesis that the average mean values
across categories of GROUP were equal. In the presence of significance for the omnibus
ANOVA test, Tukey multiple comparison test is used to perform pairwise comparisons. Statistics
were performed using WINKS SDA Software (Texasoft, Cedar Hill, TX.)

Results

Reelin Increases Neurogenesis in hNPCs

We have previously shown that Reelin treatment of hNPCs in vitro induces a neurogenic radial
glial phenotype that was characterized by the induction of BLBP expression in the bipolar GFAP
positive cells (Figure 7). Since radial glial cells were reported to serve as neural progenitors for
the majority of neurons in the CNS2, 3 and since all the neuronal population in the mouse brain
were found to be derived from radial glial cells expressing BLBP3, then we hypothesized that
Reelin may increase neurogenesis by increasing the generation of BLBP positive radial glial
cells.

To investigate this hypothesis, we co-cultured hNPCs with HEK293 cells that stably express
Reelin in a culture insert (Figure 12), as described in materials and methods section. HEK293
cells that were stably transfected with an empty vector and thus lack the expression of Reelin
were used as the control. Three days after the co-culture, hNPCs were fixed and stained with
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Nestin as a marker for proliferating radial glial cells and Doublecortin (DCX) as a marker for
newly born neurons (Figure 13).

To confirm that Reelin was able to pass through the membrane and diffuse into the hNPCs
media, we checked the level of Reelin in the media from inside (HEK293 media) and outside
(hNPCs media) of the culture insert 3 days after the co-culture. To detect both exogenous mouse
and endogenous human Reelin, we used Reelin antibody clone 142. As shown in (Figure 12),
Reelin is present in the media of the hNPCs only after the co-culture with the HEK293 cells that
express Reelin; this confirms that these hNPCs do not produce Reelin by themselves and that
Reelin can pass through the insert’s membrane.

As supporting our previous results, Reelin treatment significantly increased the percentage of the
bipolar radial glial cells in vitro (Figure 13). Radial glial cells were characterized as bipolar
Nestin positive cells that extended a process longer that 50µm11, 46. The percentage of the radial
glial cells increased from (10.17±0.67) % in the control treated cells to (18.51±0.80) % in the
Reelin treated cells, *p<0.05. Most importantly, Reelin treatment increased the percentage of the
DCX immuno-positive cells from (7.13±0.52) % in the control treated cells to (22.44±0.46) % in
the Reelin treated cells, (**p<0.05) (Figure 13). This suggests that in addition to Reelin’s role in
inducing the formation of neurogenic radial glia, it can also enhance neurogenesis in hNPCs in
vitro.
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Figure 12: Reelin expression in the media of HEK293 cells and the media of hNPCs.
Reelin expression was confirmed in the media of HEK293 cells that were stably transfected with
Reelin and plated in the insert and in the media of the underlying hNPCs after 3 days of the coculture using western blotting. Reelin antibody clone 142 was used to detect the expression of
both endogenous human and exogenous mouse Reelin. Reelin is shown to be present in the
media of the hNPCs only after the co-culture with HEK293 cells that express Reelin.
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Figure 13: Reelin increases neurogenesis in hNPCs in vitro.
The hNPCs were co-cultured for 3 days with HEK293 cells that express Reelin. The cells were
then fixed and stained with anti-Nestin (red) and anti-Doublecortin (green). Reelin treatment of
the hNPCs increased the percentage of the bipolar radial glial cells from (10.17±0.67) % to
(18.51±0.80) %, *p<0.05, and increased the percentage of the Doublecortin immunopositive
neurons from (7.13±0.52) % to (22.44±0.46) %, **p<0.05. Blue is a DAPI for nuclei
counterstaining. The data points represent the mean ± standard error of at least three independent
experiments. One-way ANOVA followed by Tukey’s post-hoc test was used for the statistical
analysis. Values that are significantly different from each other according to Tukey's test are
indicated by asterisks. Scale bars in the figure represent 100 µm.
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Reelin-induced NICD Levels is not via Increased Notch-1 Processing by γ-secretase

In our previous study (Figure 10), we reported that treating hNPCs with Reelin increases the
levels of NICD. To confirm our results we treated the hNPCs with control- or Reelin-conditioned
media for 0, 3, 6, and 12 hours. As shown in (Figure 14), Reelin treatment increases NICD
accumulation as early as 3 hours. After 6 hours of treatment, NICD levels reaches a peak
(**p<0.05), and the level of the full length Notch-1 is significantly reduced (*p<0.05).
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Figure 14: Reelin treatment increases NICD levels in hNPCs.
The hNPCs were treated with control- or Reelin-conditioned media for 0, 3, 6 and 12 hours
before isolation. The levels of full length Notch-1 and NICD were normalized to β-actin levels.
Reelin treatment increased NICD accumulation as early as 3 hours. After 6 hours of treatment,
NICD level reaches a peak (**p<0.05), and the level of the full length Notch-1 is significantly
reduced (*p<0.05). The data points represent the mean ± standard error of at least three
independent experiments. One-way ANOVA followed by Tukey’s post-hoc test was used for the
statistical analysis. Values that are significantly different from each other according to Tukey's
test are indicated by asterisks.
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NICD accumulation can be either due to increased processing of Notch-1, reduced degradation
of NICD54 or both. To examine if Reelin activates γ-secretase to enhance the processing of
Notch-1 and to increase the release of NICD from the membrane, we performed an in vitro assay
to measure the changes in the activity of γ-secretase after Reelin treatment. The hNPCs were
treated with control- or Reelin- conditioned media for 12 hours. As a control, the hNPCs were
treated with either 0.1% DMSO or 10 µM of the γ-secretase inhibitor (GSI) L-685,458 for 12
hours. As shown in (Figure 15), inhibiting the activity of γ-secretase using the inhibitor L685,458, reduced the enzymatic activity of γ-secretase from (4.25±0.28) % to (1.32±0.13) %,
*p<0.05. However, we didn’t observe any significant changes in the activity of γ-secretase after
Reelin treatment.
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Figure 15: Reelin does not enhance γ-secretase activity in vitro.
To determine if Reelin activates γ-secretase, we measured the changes in the activity of γsecretase using an in vitro assay after Reelin treatment. Treating hNPCs with 10 µM of the γsecretase inhibitor L-685,458 for 12 hours, reduced the enzymatic activity of γ-secretase from
(4.25±0.28) % to (1.32±0.13) %, *p<0.05. However, we didn’t observe any significant changes
in the activity of γ-secretase after Reelin treatment. The data points represent the mean ±
standard error of at least three independent experiments. One-way ANOVA followed by Tukey’s
post-hoc test was used for the statistical analysis. Values that are significantly different from
each other according to Tukey's test are indicated by asterisks. GSI stands for γ-secretase
inhibitor.
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Nevertheless, we thought that Reelin might be enhancing γ-secretase- mediated processing of
Notch-1 by enhancing Notch-1 trafficking into sites of high γ-secretase activity. It has been
documented that endocytosis of Notch-1 into early endosomes is important for Notch-1
activation55. Early endosomes have been identified to have high γ-secretase activity due to its
low pH value56, 57.

In order to determine if Reelin enhances Notch-1 trafficking to the early endosomes, we treated
hNPCs with 0.5 M sucrose solution to inhibit cell endocytosis, as described in materials and
methods. The hNPCs were treated with either control- or Reelin-conditioned media for 15
minutes at 4˚C to allow Reelin binding to the cells. The cells were then washed and treated with
0.5M sucrose solution for 30 minutes at 37˚C. In addition, we inhibited the activity of γ-secretase
in the hNPCs as a reference point to compare it to the inhibition of NICD release by the sucrose
treatment. Similarly, the cells were treated with control- or Reelin-conditioned media for 15
minutes at 4˚C to allow Reelin binding to the cells. The cells were then washed and treated with
10 µM of the γ-secretase inhibitor (GSI) L-685,458 for 30 minutes at 37˚C.

As shown in (Figure 16, c), γ-secretase inhibition in the Reelin treated cells shifted NICD signals
from diffused cytosolic signals as in (Figure 16, b) to membrane-bound signals. On the other
hand, the inhibition of endocytosis using a hypertonic sucrose solution caused accumulation of
Notch-1 on the cell surface and reduced its entry into the early endosomes (Figure 16, d).
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Inhibiting γ-secretase activity in the Reelin treated cells reduced NICD levels from (1.97±0.05)
fold to (1.01±0.12) fold, *p<0.05. On the other hand, treating the cells with the hypertonic
sucrose solution reduced the NICD levels in the Reelin treated cells to only (1.60±0.08) fold,
**p<0.05. These data suggest that although the inhibition of endocytosis in the Reelin treated
cells reduced the Reelin-induced NICD levels, it did not completely abolish Reelin’s effect on
NICD accumulation, indicating that Reelin increases NICD levels by a mechanism that does not
involve enhanced γ-secretase processing of Notch-1.
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Figure 16: Reelin-induced NICD accumulation is not due to enhanced Notch-1 endocytosis
To investigate if Reelin increases NICD levels by enhancing Notch-1 endocytosis, we remeasured NICD levels after inhibiting endocytosis using 0.5M sucrose solution. The hNPCs
were treated with control- or Reelin-conditioned media for 15 minutes at 4˚C. The unbound
Reelin was washed away using PBS and the cells were further incubated with 0.5M sucrose in
for 30 minutes at 37˚C. We inhibited the activity of γ-secretase in the hNPCs as a reference point
to compare it to the inhibition of NICD release by the sucrose treatment. (a-b) Reelin treatment
increased the levels of cytosolic NICD (red) when compared to the control treated cells. (c)
Inhibiting γ-secretase activity in the Reelin treated cells shifts the cytoplasmic signal of NICD
(red) into membrane-bound and reduced the fold change in the NICD levels from (1.97±0.05)
fold to (1.01±0.12) fold, *p<0.05. (d) The inhibition of endocytosis using 0.5 M sucrose retained
Notch-1 on the membrane and reduced NICD levels in the Reelin treated cells to only
(1.60±0.08), **p<0.05. The data points represent the mean ± standard error of at least three
independent experiments. One-way ANOVA followed by Tukey’s post-hoc test was used for the
statistical analysis. Values that are significantly different from each other according to Tukey's
test are indicated by asterisks. Scale bars for a and b are 100 µm and for c and d are 50 µm. GSI
stands for γ-secretase inhibitor.
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We have previously shown that the Reelin-induced BLBP expression and the subsequent
formation of the neurogenic radial glial cells were dependent on NICD generation (Figure 9). To
determine if the Reelin-induced neurogenesis is dependent on NICD generation as well, we
inhibited the activity of γ-secretase in the Reelin treated cells using the γ-secretase inhibitor (L685,458). The hNPCs were co-cultured with HEK293 cells that stably express Reelin for 3 days
and the maintenance media was supplemented with 10 µM of γ-secretase inhibitor (L-685,458).

As shown in (Figure 17), the inhibition of γ-secretase activity in the Reelin treated cells reduced
the percentage of the radial glial cells from (18.51±0.80) % to (3.9±0.29) % (*p<0.05), and
reduced the percentage of Reelin-generated neurons from (22.44±0.46) % to (14.8±0.33) % (**
p<0.05).
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Figure 17: Inhibition of Notch-1 signaling in the Reelin treated cells increases the ratio of
the generated neurons to the produced radial glia.
The inhibition of γ-secretase activity in the Reelin treated cells significantly reduced the
percentage of the radial glial cells to (3.9±0.29) %, *p<0.05, and reduced the Reelin-generated
neurons to only (14.8±0.33) %, **p<0.05. The data points represent the mean ± standard error of
at least three independent experiments. One-way ANOVA followed by Tukey’s post-hoc test
was used for the statistical analysis. Values that are significantly different from each other
according to Tukey's test are indicated by asterisks. GSI is the γ-secretase inhibitor L-685,458.
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Notch-1 is Trafficked in the Same Vesicles as Reelin and VLDLR

To gain insight into the possible mechanism by which Reelin acts on Notch-1, we investigated
the localization of Reelin and its receptors relative to Notch-1 before and after Reelin treatment.
The hNPCs were treated with either control- or Reelin- conditioned media for 15 minutes at 4˚C
to allow Reelin binding to the cells. The cells were then washed and incubated for 30 minutes at
37˚C to allow Reelin internalization. The treated hNPCs were then fixed and stained with Reelin
antibody clone 142 to detect both human and mouse Reelin. As expected, we didn’t observe any
Reelin staining in the control treated cells (data not shown), indicating that the positive stain we
observed in the Reelin treated cells corresponds to the mouse Reelin that we used for treating the
cells. As shown in (Figure 18), Reelin co-localized with Notch-1 in intracellular vesicles that are
similar to the vesicles that contained Reelin and its receptor VLDLR.
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Figure 18: Notch-1 is trafficked in the same vesicles as Reelin and VLDLR.
The co-localization of Reelin and Notch-1 was examined before and after Reelin treatment. The
hNPCs were treated with either control- or Reelin-conditioned media for 15 minutes at 4˚C to
allow Reelin binding to the cells. The cells were then washed and incubated for 30 minutes at
37˚C to allow Reelin internalization. The treated hNPCs were fixed and stained with Reelin
antibody clone 142 to detect both human and mouse Reelin. (a-c) Reelin (green) co-localizes
with VLDLR (red). (d-f) Reelin (green) co-localizes with Notch-1 (red). Short arrows point to
intracellular vesicles that showed co-localization while long arrows point to vesicles without colocalization. Blue is a DAPI for nuclei counterstaining. Scale bars are 20 µm.
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Dab-1 Tyrosine Phosphorylation is Essential to Mediate Reelin-induced Notch-1 Activation

Once Reelin binds its receptors VLDLR and ApoER2, Reelin signal gets propagated into the
cells via the induction of Dab-1 tyrosine phosphorylation and the activation of downstream Src
family kinases15-17.

To examine if Dab-1 tyrosine phosphorylation is important to mediate Reelin’s effect on NICD
accumulation, we used a Dab-1 mutant that cannot be tyrosine phosphorylated because its 5
tyrosine residues have been mutated into phenylalanines (Dab-1 5F)
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. We transfected hNPCs

with wild type Dab-1 (Dab-1 WT) and the mutant Dab-1 5F for 24 hrs and then treated the cells
with control or Reelin-conditioned media for 1 hour. Dab-1 tyrosine phosphorylation was
confirmed by immunoprecipitating Dab-1 from all the collected samples using an antibody
against Dab-1 C-terminus, running the immunoprecipitated proteins on SDS-PAGE and then
blotting the membranes with an antibody that recognizes the tyrosine phosphorylated Dab-1 on
tyrosine residue 198.

As shown in (Figure 19), Dab-1 WT transfection had no significant effect on the levels of NICD.
However, Dab-1 WT transfection with Reelin treatment had synergistic effect and increased the
levels of NICD to a level higher than that obtained with Reelin treatment only, (*p<0.05). Most
importantly, Dab-1 5F mutant transfection resulted in complete loss of Reelin’s effect on NICD
accumulation and brought NICD levels close to basal levels, (**p<0.05). These data indicate that
the induction of Dab-1 tyrosine phosphorylation by Reelin is important to mediate Reelin’s
effect on NICD accumulation.
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Figure 19: Reelin-induced activation of Notch-1 is dependent on Dab-1 tyrosine
phosphorylation.
The involvement of Dab-1 tyrosine phosphorylation in NICD accumulation was tested by the
over-expression of Dab1 5F mutant. As a control, the cells were transfected with wild type Dab1 (Dab-1 WT). Dab-1 tyrosine phosphorylation was assessed by Western blotting of
immunoprecipitated Dab-1 with Dab-1(phospho Y198) antibody. Reelin treatment induced Dab1 tyrosine phosphorylation and NICD accumulation (*p<0.05) in all the samples but the ones
transfected with Dab-1 5F mutant (**p<0.05). The data points represent the mean ± standard
error of at least three independent experiments. One-way ANOVA followed by Tukey’s post-hoc
test was used for the statistical analysis. Values that are significantly different from each other
according to Tukey's test are indicated by asterisks. Dab1-RFP stands for Dab-1 with a red
fluorescent protein (RFP) tag.
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Inhibition of Src Family Kinases Blocks Reelin-induced NICD Accumulation

Since Dab-1 is tyrosine phosphorylated by Src family kinases and since Dab-1 tyrosine
phosphorylation acts to further activate these kinases16, we examined if the activity of Src family
kinases is also important to mediate Reelin’s effect on NICD accumulation.

Therefore, we pre-treated hNPCs for 1 hour with 10 µM of either the Src inhibitor PP2 or PP2’s
inactive analog PP3 as a control. The cells were then treated with either control or Reelinconditioned media for 1 hour in the presence of these inhibitors. As shown in (Figure 20),
inhibiting Src kinases using PP2 inhibited Dab-1 tyrosine phosphorylation and the accumulation
of NICD in the Reelin treated cells, (*p<0.05).
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Figure 20: Reelin-induced activation of Notch-1 is dependent on Src activation.
The hNPCs were pre-treated for 1 hour with 10µM of the Src inhibitor PP2 or its inactive analog
PP3 to investigate the importance of the activation of Src family kinases on NICD accumulation
in response to Reelin. The cells were then treated with control or Reelin-conditioned medium for
1 hour in the presence of the inhibitors. The inhibition of Src activity inhibited Dab-1 tyrosine
phosphorylation and NICD accumulation in the Reelin treated cells (*p<0.05). The data points
represent the mean ± standard error of at least three independent experiments. One-way ANOVA
followed by Tukey’s post-hoc test was used for the statistical analysis. Values that are
significantly different from each other according to Tukey's test are indicated by asterisks.
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Reelin Does not Bind to Notch-1

In addition, we tested the possibility of a direct interaction between Reelin and Notch-1 using coimmunoprecipitation. The hNPCs were treated with control or Reelin-conditioned media for 15
minutes to allow Reelin binding to the cell surface. The unbound Reelin was then washed away
with PBS and the cells were isolated. However, although we found an interaction between Reelin
and VLDLR after Reelin treatment, we couldn’t detect any interaction between Notch-1 and
Reelin (Figure 21). These data confirm that Reelin effect on Notch-1 is mediated by intracellular
signals rather than by Reelin and Notch-1 direct interaction.
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Figure 21: Reelin does not bind Notch-1.
(a) The hNPCs were treated with Reelin for 15 minutes at 4°Cto allow Reelin to bind the cell
surface. The unbound Reelin was then washed away with PBS. The cells were then fixed and
stained with anti-Reelin. Reelin stain (green) confirms that Reelin was bound to the cell surface
without being internalized. Blue is a DAPI for nuclei counterstaining (b) Western blot that shows
the levels of Notch-1, Reelin and VLDLR in the cell lysate. (c) Co-immunoprecipitation against
Notch-1 didn’t yield Reelin or VLDLR. (d) Co-immunoprecipitation against Reelin yielded
VLDLR after Reelin treatment but didn’t yield Notch-1.
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Reelin Increases NICD Translocation to the Nucleus

Next, we examined NICD localization in the cells after Reelin treatment. The cells were treated
with control or Reelin-conditioned media for 12 hours before fixation. The cells were then
stained with a Notch-1 antibody that has a high affinity to Notch-1 intracellular domain and with
BLBP antibody, a gene downstream of NICD. As shown in (Figure 22), Notch-1 localizes on the
membrane or in vesicular structures before Reelin treatment with only basal levels of BLBP
expression in these cells. Reelin treatment resulted in the translocation of NICD to the nucleus
and the induction of BLBP in these cells.
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Figure 22: Reelin increases NICD translocation to the nucleus and induces BLBP
expression.
To examine NICD localization after Reelin treatment, hNPCs were treated with control or
Reelin-conditioned media for 12 hours. The cells were then fixed and stained with anti-Notch1
(green). The cells were also stained with anti-BLBP (red) to confirm the expression of BLBP in
the Reelin treated cells that contain nuclear NICD. In the control treated cells, Notch-1 signal is
mainly membrane-bound without any nuclear staining, short arrows point to the nuclei with
negative Notch-1 immunoreactivity. Reelin treatment shifted Notch-1 signal from the membrane
to the nucleus and induced BLBP expression, long arrows point to the nuclei with positive
Notch-1 immunoreactivity. Blue is a DAPI for nuclei counterstaining. Scale bar is 50 µm.
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Reelin Increases Dab-1 Binding to NICD in the Nucleus

Next, we investigated if Reelin can increase the interaction between Dab-1 and NICD in the
nucleus. Dab-1 was recently identified as a nucleoshuttling protein50. The hNPCs were treated
with control or Reelin-conditioned media for 12 hours before isolation. The cell lysates were
then fractioned and the nuclear fractions were used to co-immunoprecipitate Dab-1and NICD.
As shown in (Figure 23), Reelin treatment increased the level of NICD that coimmunoprecipitated with Dab-1 (Figure 23, b) and increased the level of Dab-1 that coimmunoprecipitated with NICD (Figure 23, a) in the nuclear fraction. These data indicate that
Reelin treatment can increase the interaction between NICD and Dab-1 in the nucleus.
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Figure 23: Reelin enhances the binding between Dab-1 and NICD in the nuclear fraction.
The hNPCs were treated with control or Reelin-conditioned medium for 12 hours before cell
extraction. NICD and Dab-1 were co-immunoprecipitated from the nuclear fraction using antiNICD (a) and anti-Dab-1 (b) antibodies, respectively. Reelin treatment increased Dab-1 and
NICD interaction in the nucleus.
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Discussion

We have previously shown that Reelin treatment of fetal cortical hNPCs in vitro induces
neurogenic radial glial cells51. Since it has been found that radial glial cells serve as neural
progenitors for the majority of neurons in the CNS2, 3, and since all the neuronal population in
the mouse brain were found to be derived from radial glial cells that express BLBP3, we
questioned if our Reelin-induced BLBP positive radial glia can produce neurons. As shown in
(Figure 13), we found that Reelin addition to the hNPCs for 3 days enhances their neurogenic
potential and increases the percentage of the DCX immuno-positive cells from (7.13±0.52) % in
the control treated cells to (22.44±0.46) % in the Reelin treated cells, (**p<0.05).

To determine if Reelin’s effect on neurogenesis is dependent on Notch-1 activation, we reanalyzed the hNPCs’ neurogenic potential after inhibiting the activity of γ-secretase.
Surprisingly, inhibiting Notch-1 activation in the Reelin treated cells did not reduce the
generation of neurons dramatically and therefore increased the ratio of the generated neurons to
the produced radial glia (Figure 17). This can be explained by considering the role of Notch-1
signaling in cell fate determination during the asymmetric division of the radial glial cells4. As
the radial glial cell is asymmetrically dividing, one of the daughter cells inherits the protein
Numb. This protein will inhibit the activity of Notch-1 in that cell driving it to acquire the
neuronal fate. On the other hand, Notch-1 will remain activated in the other daughter cell driving
it to become a radial glia4. Accordingly, performing the co-culture in the presence of the Notch-1
inhibitor will result in the transformation of both daughter cells into neurons and increasing the
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ratio of the generated neurons to the produced radial glia cells. On the long term this will result
in the depletion of the neuronal progenitors and reduction in the overall rate of neurogenesis.

The first step in the activation of Reelin signaling is the induction of Dab-1 tyrosine
phosphorylation15. The tyrosine phosphorylated Dab-1 acts as link between Reelin and its
downstream kinases. Dab-1 tyrosine phosphorylation forms a binding site for Src family kinases
resulting in their activation and leading to further phosphorylation of Dab-1 on its remaining
tyrosine residues16, 17. This will further activate Src and will ultimately result in the activation of
the kinases PI3-K and Akt17. To determine if Dab-1 tyrosine phosphorylation is crucial to
mediate the effect of Reelin on Notch-1 activation, we used a Dab-1 mutant that cannot be
tyrosine phosphorylated in response to Reelin53. The use of this mutant completely abolished
Reelin’s effect on Notch-1 activation and brought NICD levels back to basal levels (Figure 19).
Similarly, inhibiting the activity of Src inhibited the effect of Reelin on NICD accumulation
(Figure 20). Interestingly, Reelin treatment was also found to enhance the interaction between
Dab-1 and NICD (Figure 23) and increased NICD translocation to the nucleus (Figure 22).

Notch-1 activation and the release of NICD from the membrane depend on two sequential
proteolytic events of Notch-1. The first step is initiated after Notch-1 binding to its ligand on the
cell membrane. Notch-1 extracellular domain gets endocytosed into the signal-sending cell and
the rest of the receptor undergoes cleavage by a protease of the ADAM family. This yields an
extracellular fragment and a membrane bound fragment that serve as the precursor for the second
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cleavage. The second cleavage is mediated by γ-secretase, which usually takes place in the early
endosomes. This yields the final fragment of Notch-1, NICD58.

In our study, Reelin treatment did not increase Notch-1 processing by γ-secretase (Figure 15 &
16). Since Notch-1 full length levels were reduced after Reelin treatment (Figure 14), Reelin
might increase the levels of the NICD precursor by enhancing the processing of the full length
Notch-1 on the cell surface leading to increased NICD levels. In addition, a recent study has
showed that the activation of Reelin signaling can directly act on inhibiting NICD degradation
via the proteasome54, this indicates the Reelin is also acting downstream of γ-secretase to
increase the levels of NICD.

In conclusion, Reelin and Notch-1 pathways are two important pathways in development. We
recently reported their crosstalk and showed that Reelin signaling pathway can act to fine tune
Notch-1 activation to favor the induction of neurogenic radial glial cells in hNPCs. Here, we
investigated the molecular mechanisms by which Reelin activates Notch-1. This study furthers
our knowledge about the molecular regulation of Notch-1 activity in cell fate determination and
provides us with new targets to manipulate the process of neurogenesis.
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CHAPTER FOUR:
DISABLED-1 PROMOTES γ-SECRETASE-MEDIATED PROCESSING OF
AMYLOID PRECURSOR PROTEIN
Introduction
β- Amyloid precursor protein (APP) is the precursor of amyloid β peptide (Aβ), which is
associated with the pathogenesis of Alzheimer’s disease (AD), a progressive neurodegenerative
disease33. The APP gene is alternatively spliced to produce three different isoforms of 695, 751
and 770 amino acids in length, where APP695 is the major isoform in neurons. The product of
this isoform is an integral type I transmembrane glycoprotein that has a large amino terminal
extracellular/ luminal domain and a short cytoplasmic tail34.

APP is trafficked through the constitutive secretory pathway where it matures into the Oglycosylated form in the Golgi apparatus35. During trafficking, APP is subjected to processing by
proteolytic enzymes that are distributed throughout the secretory and the endocytic pathways to
generate different APP fragments, which in turn regulate several neural functions including cell
excitability, synaptic transmission and long-term potentiation36.

Processing of APP is initiated via the proteolytic activities of α- and β-secretases, which cleave
APP ectodomain close to its transmembrane domain to liberate soluble APP extracellular
fragments (α- or β-sAPP respectively). APP cleavage by α- or β-secretases is a key regulatory
process in the generation of the Aβ.
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β-secretase has been identified as the aspartyl protease BACE1 and has been localized in the
trans-Golgi network (TGN) and endosomes, where it cleaves APP at the N-terminus of the Aβ
peptide domain catalyzing the first step in Aβ peptide generation. In contrast, α-secretase is
found at the cell surface and cleaves APP within the Aβ sequence thereby precluding its
generation.

After the initial cleavage of APP by α- and/or β-secretase, the remaining membrane-tethered Cterminal APP fragments (CTFs), are further cleaved within its transmembrane domain by a
multimeric protein complex termed γ-secretase to generate p3 and A
cytosolic APP intracellular domain (AICD)

33-36

respectively, and a

. The specific localization of γ-secretase activity

remains controversial, however recent studies have localized it to the trans-Golgi network
(TGN) and the endosomal/lysosomal compartments, the major sites of Aβ generation56, 57, 59, 60.

Recent evidence shows that APP processing is regulated by proteins that bind its intracellular
domain, particularly its YENPTY motif, which contains the consensus sequence for the
clatherin-coated pit internalization37, 38. Deletion of this motif impairs APP internalization and
decreases Aβ secretion by precluding endosomal/lysosomal APP processing61, 62.

Most of the proteins found to bind this motif are adaptor proteins possessing the
phosphotyrosine-binding (PTB) domain, such as Fe65, X11, JIP and Dab protein families. These
proteins bridge APP to different complexes that can assemble around its intracellular domain to
regulate its trafficking and metabolism37, 38. The X11 family of adaptor proteins (X11 α, β, γ), for
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example, has been shown to bind and to stabilize cellular APP, increase its half-life and reduce
the production and secretion of sAPPα, Aβ40 and Aβ4263-66.

On the other hand, Disabled-1 (Dab-1) effect on APP processing has only recently been
investigated67, 68. Dab-1 is a cytoplasmic adaptor protein that has been extensively studied as a
key element in the Reelin-signaling pathway controlling neuronal migration, laminar positioning
and organization. It transmits Reelin signal by binding the NPXY motif of the Reelin receptors,
very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoEr2), via its
PTB domain, serving as a link between Reelin and downstream kinases15-17. Mutation in Dab-1
generates a reeler-like phenotype, which is characterized by inversion of the cortical layers and
abnormalities in the laminated brain structures18. Interestingly, disrupting APP and its two
homologues amyloid precursor-like protein (APLPs) 1 and 2, results in cortical dysplasia and
neuronal migration defects69 that are a similar but not identical to disruption of Reelin, Dab-1 or
its receptors ApoER2 or VLDLR18.

Recently, Dab-1 over-expression was reported to increase the cell surface expression level of
APP, increase APP α-cleavage67, 68 and reduce its β-cleavage in transfected cells and in primary
neurons68. In this study, we investigated the effects of Dab-1 over-expression on APP cleavage
by γ-secretase, the final step in APP processing. We report that Dab-1 over-expression increases
the γ-secretase-mediated processing of APP, resulting in increased release of APP intracellular
domain (AICD) from the membrane.
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Materials and Methods

Cell Culture

NT2/ D1 cells, human neuron-committed teratocarcinoma cell line, were maintained in
Dulbecco’s Modified Eagle’s Medium (DMEM/F12) supplemented with 10% fetal bovine serum
(FBS) (Invitrogen), 1% antibiotic-antimycotic (Invitrogen) and 1% glutamate (Invitrogen), in a
5% CO2 incubator at 37˚C. NT2 cells were cultured in six-well plates (BD biosciences) and
transiently transfected with 4 g of plasmid using Lipofectamine 2000 reagent according to the
manufacturer’s instructions (Invitrogen). The cells were cultured for 24 hours post transfection in
DMEM/F12 medium supplemented with 10% FBS and 1% glutamate.

For γ-secretase inhibition, 6 hours post transfection, the media was totally removed and 10 M
of γ-secretase inhibitor (L-685, 458 - Sigma Aldrich) or 0.1% Dimethysulfoxide (DMSO- Sigma
Aldrich) as control, were prepared in growth media and added to the cells for 12 hours before
lysis. For proteasomal inhibition, 6 hours post transfection, the media was totally removed and
the cells were incubated with 50 M MG-132 (CalBioChem) or 0.1% DMSO as a control in
growth media for 6 hours at 37 ˚C before lysis. For lysosomal inhibition, the cells were treated
with 100 M of the lysosome inhibitor chloroquine (Sigma Aldrich) for 6 hours at 37 ˚C.

cDNA constructs. Dab-1 gene (Accession # NM_021080) was isolated from Human Neural
Stem cells and cloned into pcDNA3.1 vector with FLAG tag on its C terminus (Invitrogen);
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sequencing was performed to assure that the clone is in frame. pCEP-APP-GFP and pCEPAPP695 were kindly provided by Dr. Beth Ostaszewski, Harvard Medical School. Dab1-ΔPTB
in pEF-BOS expression vector was kindly provided by Dr Shiro Suetsugu, The University of
Tokyo.

Immuncytochemistry and Microscopy
Cells were fixed with 4% Paraformylaldehyde (Sigma Aldrich) for 24 hrs at 4˚C. The next day,
the cells were washed three times with phosphate buffered saline (PBS- Sigma Aldrich ) at room
temperature and blocked with 3% donkey serum (Jackson ImmunoResearch Labs) in phosphate
buffered saline with 0.1% Triton X ( PBST- Sigma Aldrich) for 1 hour at room temperature. The
cells were then incubated with the appropriate antibody for 24 hrs at 4˚C. After washing the cells
with PBS for three times the cell were incubated with anti-rabbit or anti-mouse Tetramethyl
Rhodamine Iso-Thiocyanate (TRITC)-conjugated antibodies (1: 500 Jackson ImmunoResearch
Labs) for 2 hrs at room temperature in the dark. The cells were washed again and mounted with
vectashield with DAPI (vector laboratories) to stain nuclei and for microscopic observations.
Microscopic images were taken with the QImaging MicroPublisher 5.0 color digital imaging
system and processed using the QCapture software (Leeds, Irving, TX)

Primary antibodies that have been used: mouse anti- EEA1 (1:200; Abcam), rabbit Dab-1
antibody (1:1000; Abcam), mouse anti-Cathepsin D (1:200; Abcam), rabbit anti-Mannosidase II
(1:200; Abcam) and rabbit anti-Calreticulin (1:200; Abcam).
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Western Blot Analysis and Immunoprecipitations

NT2 Cells were lysed 24 hr post-transfection in ice-cold lysis buffer containing 1% Nonidet P40, 150 mM NaCl, 50 mM Tris (pH 8.0), and protease inhibitor mixture (Roche, Indianapolis,
IN). The homogenates were centrifuged at 12,000 x g for 30 min at 4°C and the supernatants
were saved for analysis. 30 µg of protein was loaded per well, and proteins were separated by
SDS/PAGE (NuPage 4%-12% Bis-Tris, Invitrogen) and then blotted onto polyvinyldiene
difluride (PVDF) membranes (Bio-rad) for 120 min at 30 V. The membranes were then
immunoblotted with the following antibodies overnight at 4˚C: Anti-Amyloid Precursor Protein
C-terminal (1:1000; Sigma Aldrich), anti-Dab-1 (1:1000; Abcam), anti-β actin (1:1000; Cell
Signaling), anti-ubiquitin (1:1000; Cell Signaling), and mouse anti- beta amyloid (6E10) (1:250;
Abcam). After washing, membranes were incubated with horseradish peroxidase-conjugated
secondary antibodies (anti-mouse IgG and anti-rabbit IgG; Jackson Immunoresearch, West
Grove, PA) for 1–2 h. Signals were detected by chemiluminescence using the enhanced
chemiluminescence (ECL) system (Amersham Biosciences Corp) on a Kodak Imaging Station
IS2000MM. The optical density of each specific band relative to

-actin was analyzed by the

public domain National Institutes of Health Image J software. For immunoprecipitations, 600µg
of protein was incubated for 3 hours at 4°C with the primary antibody Anti-Amyloid Precursor
Protein C-terminal (1:1000; Sigma Aldrich). Protein A-Sepharose beads were added for 1 hr at
4°C, and then immunoprecipitates were washed 5X with lysis buffer. Immunoprecipitated
proteins were solubilized in 1% SDS solution and resolved on a 4-12% Bis-Tris gel (Invitrogen).
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RNA Isolation and Real Time RT-PCR

The RNA of each sample was isolated at a specific time point using TRIZOL reagent according
to the manufacturer’s instructions. The quantification of each of the gene transcripts was done by
real-time RT-PCR using I script one-step RT-PCR kit with SYBR green (Bio-Rad Laboratories
Inc) according to manufacturer’s instructions. Reactions were done in duplicates using I-Cycler
from Bio-Rad and the threshold values (Ct) were averaged after dropping reactions with PCR
inhibitors or a varying slope. The PCR efficiency for each gene transcript using a specific set of
primers was measured from a standard curve done for each transcript using two-fold serial
dilutions, the correlation coefficient was found to be higher than .98 for each curve and the PCR
efficiencies values was found to be, for -actin 94%, Dab-1 98%, and APP 95%. These values
were then incorporated in PFAFFL equation70 along with the averaged threshold values to
calculate the fold change in the gene expression relative to the fold change in the reference gene;
-actin was used as the reference gene that was also run in duplicates for each sample we had. 10
µl of the reaction were separated on 2% E-gel (Invitrogen).
The following primers were used:
APP (+) 5’-CTTGAGTAAACTTTGGGACATGGCGCTGC-3’
(-) 5’-GAACCCTACGAAGAAGCC-3’
-actin (+) 5’-GACAGGATGCAGAAGGAGAT-3’
(-) 5’-TTGCTGATCCACATCTGCTG-3’
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In-vitro AICD Generation Assay
AICD was generated from membranous fractions using previously described methods71, 72. In
short, the cells were lysed with buffer A (50 mM HEPES, 150 mM NaCl, 5 mM EDTA, PH 7.4)
supplemented with protease inhibitor cocktail set I (Calbiochem). The homogenates were
sequentially fractioned at 2500 xg for 15 minutes to collect unbroken cells and nuclei and the
supernatant was saved as the cytosolic fraction. The post-nuclear fraction was then centrifuged at
16,000 xg for 30 minutes and the pellet was washed once with buffer A and resuspended in
buffer B (50 mM HEPES, 150 mM NaCl, 5 mM EDTA, PH 7.0) supplemented with protease
inhibitor cocktail set I (Calbiochem). The pellet was allowed to dissolve for 4 hours at either
37˚C or 4˚C as a negative control with vigorous shaking. After the incubation was complete, the
samples were chilled on ice to stop the reactions and the membranes were collected by
centrifugation at 16,000 xg for 30 minutes (P0). The final supernatant was used for analysis to
detect AICD levels (P1).

Statistical Analysis

Each data point represents triplicated experiments and displayed as the mean ± standard error. A
one-way Analysis of Variance was performed to test the hypothesis that the average mean values
across categories of GROUP were equal. In the presence of significance for the omnibus
ANOVA test, Tukey multiple comparison test is used to perform pairwise comparisons. Statistics
were performed using WINKS SDA Software (Texasoft, Cedar Hill, TX.).
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Results

Dab-1 Overexpression Reduces APP-CT-GFP Signals in the Early Endosomes

In order to study the effects of Dab-1 on APP metabolism, we examined the effects of Dab-1
over-expression on the distribution of the GFP signals in NT2/D1 cells transfected with APP
tagged with GFP. Co-transfection of Dab-1 and APP tagged with GFP on its C-terminus (APPCT-GFP) reduced the APP-CT-GFP signals that accumulated in intracellular vesicles (Figure 24,
a-e). As shown in (Figure 24, d and e) Dab-1 co-localized with APP on the plasma membrane
(short arrow) and on the membrane of intracellular vesicles (long arrow).

Dab-1 was previously found to bind to APP via its PTB domain68. The PTB domain of Dab-1
binds the internalization motif (NPXY) located on the intracellular domain of APP37,

38

. To

determine if Dab-1 mediates its effect on APP via binding it, we used a Dab-1 mutant that has its
PTB domain deleted (Dab-1 Δ PTB). As shown in (Figure 24, i) Dab-1 Δ PTB and APP were not
observed to localize, confirming that Dab-1 Δ PTB could not bind to APP. The co-transfection of
APP-CT-GFP and Dab-1 Δ PTB resulted in an enhanced accumulation of APP in large vesicles
that surrounded the nucleus (Figure 24, g-i).
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Figure 24: Dab-1 over-expression reduces APP-CT-GFP signals in vesicular structures.
NT2/D1 cells were co-transfected with APP-CT-GFP and an empty vector as a control (a-c),
APP-CT-GFP and Dab-1 (d-e) or APP-CT-GFP and Dab-1 Δ PTB (g-i) for 24 hours. The cells
were then fixed and immunostained against Dab-1 (red) using an antibody that binds Dab-1 Cterminus and can thus recognize the wild type and the mutant Dab-1. Dab-1 over-expression
reduced the APP-CT-GFP signals in the vesicles (a-f). The co-transfection of Dab-1 Δ PTB with
APP-CT-GFP resulted in enhanced accumulation of APP-CT-GFP signals in large vesicles (g-i).
Blue is a DAPI for nuclei counterstaining. Scale bar is 50 µm.
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To identify the intracellular vesicles that APP-CT-GFP signals accumulated in, we co-localized
these signals with markers for the early endosomes (EEA1), trans-Golgi network (Mannisodase
II), the endoplasmic reticulum (Calreticulin) and the lysosome (Cathepsin D). Although faint colocalization was observed between APP-CT-GFP signals, the ER, the trans-Golgi network and
the lysosomal markers (data not shown), most of the APP-CT-GFP signals co-localized with the
early endosomal marker (Figure 25). These data suggest that the transfected APP accumulated
in the early endosomes after being endocytosed from the membrane.
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Figure 25: APP-CT-GFP signals co-localizes with the early endosomal marker (EEA1).
After transfecting NT2/D1 cells with APP-CT-GFP for 24 hours, the cells were fixed and stained
with the early endosomal marker (EEA1). Long arrow points to co-localized APP-CT-GFP
signals while short arrow points to un-localized signals. Scale bar is 20 µm.
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Dab-1 Overexpression Increases the Release of APP Intracellular Domain

Based on our observation that Dab-1 overexpression resulted in diffusion of APP-CT-GFP
signals into the cytosol, we hypothesized that Dab-1 might be increasing APP processing by γsecretase in the early endosomes to release AICD-GFP into the cytosol.

The processing of APP by γ-secretase is the final step in APP processing that results in releasing
APP intracellular domain (AICD) from the membrane33-36. To determine if Dab-1 overexpression increases AICD level, we transfected NT2/D1 cells with either an empty vector as
control or Dab-1 for 6 hours and then treated the cells with either 10 µM of the γ-secretase
inhibitor (L-685, 458) or with 0.1% DMSO as a control for 12 hours. AICD was generated invitro by incubating the samples at 37˚C for 4 hours. The supernatant (P1) fractions that were
obtained from solublizing the post-nuclear fraction were used for analysis.

As we expected, Dab-1 transfection increased AICD level relative to the empty vector
transfected cells (Figure 26-lane 2). In contrast, AICD release was completely inhibited in the
Dab-1 over-expressing cells that were treated with the γ-secretase inhibitor (L-685, 458) (Figure
26-lane 4). These data confirm that Dab-1 increases AICD release from the membrane and that
this effect is γ-secretase dependent.
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Figure 26: Dab-1 over-expression increases AICD generation.
NT2/D1 cells were transfected with Dab-1 or empty vector as a control for 6 hours. AICD
release was measured before and after Dab-1 transfection, with and without γ-secretase
inhibition. AICD was detected using an antibody that binds to APP C-terminal. Dab-1 overexpression increased AICD production (lane 2), where AICD production was totally demised by
L-685, 458 treatment (lane 4).
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APP- CTFs in the supernatant fraction (P1) seemed to accumulate after γ-secretase inhibition due
to their decreased processing (Figure 27-lanes 3 and 4). However, to further analyze Dab-1
effect on APP processing, we analyzed the change in the total level of APP-CTFs after Dab-1
transfection. The cells were again transfected with either an empty vector as a control or Dab-1
for 6 hours and the total level of APP-CTFs was analyzed in the total cell lysate and after
immunoprecipitation using an antibody against APP-C terminal (Figure 27).

Although the level of total APP-CTFs did not significantly change after Dab-1 transfection
(Figure 27-lanes 1 and 2), we saw a slight accumulation of APP-CTFs in the Dab-1
overexpressing cells only after γ- secretase inhibition (Figure 27-lanes 3 and 4).
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Figure 27: APP-CTFs slightly accumulates in the Dab-1 overexpressing cells after secretase inhibition.
The total level of APP-CTFs was analyzed after Dab-1 transfection with and without γ-secretase
inhibition. Samples were either directly ran on SDS-PAGE gel (second row) or
immunoprecipitated with APP C-terminal antibody (fourth row). The membrane was then blotted
with the same antibody.
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Recently Dab-1 was shown to enhance α-secretase mediated processing of APP67,

68

. If that

applies to our system as well, then it’s possible that Dab-1 is increasing α- and γ- cleavage of
APP equivalently resulting in no net change in the total level of APP-CTFs. Thus, only upon the
inhibition of γ-secretase activity, APP-CTFs that have been generated by α-secretase are
expected to accumulate. To confirm that in our system, we measured the amount of α-sAPP
released into the media after Dab-1 transfection using anti-6E10. The level of total sAPP was
measured using anti-22C11. The cells were transfected with Dab-1 for 24 hours before media
collection. The effects of Dab-1 over-expression on exogenous APP were also tested by cotransfecting Dab-1 and APP using APP transfection as the control. As we expected, Dab-1 overexpression significantly increased the level of both exogenous (**p<0.05) and endogenous αsAPP (*p<0.05) in the media (Figure 28).
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Figure 28: Dab-1 enhances α-secretase mediated processing of APP.
Secreted APP levels were measured in the media collected from Dab-1 over-expressing cells.
NT2/D1 Cells were transfected with empty vector (control), Dab-1 (Dab-1), APP and empty
vector (APP) and APP and Dab-1 (APP+Dab-1) for 24 hours before media collection. Dab-1
over-expression significantly increased the level of both exogenous (**p<0.05) and endogenous
α-sAPP (*p<0.05) in the media. The data points represent the mean ± standard error of at least
three independent experiments. One-way ANOVA followed by Tukey’s post-hoc test was used
for the statistical analysis. Values that are significantly different from each other according to
Tukey's test are indicated by asterisks.
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Figure 29: A schematic diagram that illustrates the effects of Dab-1 on APP processing.
Dab-1 increases AICD release from the membrane by (1) Enhancing APP processing on the
membrane by α-secretase yielding APP-CTF. (2) Enhancing APP-CTF processing by γsecretase.
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Dab-1 Overexpression Promotes APP Processing by γ-secretase

To confirm that Dab-1 over-expression reduces APP-CT-GFP signals in endosomal
compartments by promoting γ–secretase activity, we inhibited the activity of γ–secretase in cells
co-transfected with Dab-1 and APP-CT-GFP. APP-CT-GFP and empty vector co-transfection
was used as the control. As we expected, γ–secretase inhibition abolished Dab-1 over-expression
effects on APP-CT-GFP signals, retaining them as membrane-bound and preventing their
cytosolic dispersion (Figure 30).
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Figure 30: Dab-1 over-expression promotes γ-secretase-mediated processing of APP.
To test if Dab-1 effect is γ-secretase-dependent , NT2/D1 cells were co-transfected with APPCT-GFP and empty vector (a-c and g-i) or APP-CT-GFP and Dab-1 (d-f and j-l) for 6 hours and
treated with either 0.1% DMSO as a control or 10 M of the γ-secretase inhibitor (L-685, 458)
for 12 hours. The cells were then fixed and immunostained against Dab-1 (red). γ-secretase
inhibition abolished Dab-1 over-expression effects on APP-CT-GFP signals retaining them as
membrane-bound (j-l). Blue is a DAPI for nuclei counterstaining. .Scale bar for (a, b, d, e, g, h, j,
k) is 72µm and for (c, f, l) is 27 µm.
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Dab-1 Overexpression Mediates APP Lysosomal Degradation

In addition to Dab-1 effect on APP processing, we observed a reduction in the level of APP-CTGFP signals as they seemed to be fainter after Dab-1 transfection (Figure 24). As a result, we
hypothesized that Dab-1 might be also increasing the degradation of APP.

A recent study found that Numb, a related adaptor protein, promotes the ubiquitination of the
membrane-tethered Notch1 and the degradation of the cleaved Notch intracellular domain
(NICD) following the receptor activation73. In addition, a direct interaction between Dab-1 and
the E3 ligase Siah 1 has been previously reported74.

To further delineate Dab-1 effect on APP metabolism, we tested if Dab-1 over-expression can
mediate the degradation of APP. NT2/D1 cells were transfected with either Dab-1, Dab-1 Δ PTB
or an empty vector as a control. The cells were then treated with either 50 M of the proteasome
inhibitor MG-132 or with 0.1% DMSO as a control for 6 hours at 37 C before lysis. The
accumulation of the ubiquitinated proteins in the cells treated with MG-132 was confirmed by
analyzing the levels of the ubiquitinated proteins in the treated samples using antibody against
ubiquitin (Figure 31).

As shown in (Figure 32) Dab-1 transfection resulted in reducing APP levels relative to the empty
vector transfection (lane 2). On the other hand, the transfection of Dab-1 Δ PTB prevented the
degradation of APP (lane 3). Interestingly, inhibiting the proteasome using MG-132 did not
recover APP levels in the Dab-1 transfected cells (lane 5).
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In (Figure 24) we observed that transfecting the Dab-1 mutant (Dab-1 Δ PTB) prevented the
clearance of APP from the early endosomes, resulting in marked accumulation of APP in
enlarged endosomal structures that surrounded the nucleus. It’s possible that Dab-1
overexpression enhances the trafficking of APP from the early endosomes to the lysosomes
leading to clearance of APP from the early endosomes and increased APP degradation in the
lysosome.

To determine if Dab-1 increases APP degradation via the lysosome instead, we inhibited the
lysosomal degradation in the Dab-1 transfected cells. NT2/D1 cells were transfected with either
an empty vector, Dab-1 or Dab-1 Δ PTB. The next day, the cells were treated with either 0.1%
DMSO as a control or with 100 µM of the lysosomal inhibitor Chloroquine for 6 hours.

As expected, inhibiting the lysosome recovered APP levels in the Dab-1 transfected cells (lane
8), indicating that Dab-1 binding to APP mediates the trafficking of APP from the endosomes to
the lysosome for degradation.
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DMSO

( + ) MG-132

Ubiquitin

Figure 31: Accumulation of ubiquitinated proteins after MG-132 treatment.
NT2/D1 cells were transfected with either empty vector (control), Dab-1 or Dab-1 Δ PTB for 24
hours and then treated with either 0.1% DMSO (first four lanes) or with 50 M MG-132 (last
four lanes) for 6 hours before lysis. Accumulated ubiquitinated proteins were detected using
antibody against ubiquitin.
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Figure 32: Dab-1 overexpression increases APP degradation via the lysosome.
NT2/D1 cells were transfected with either an empty vector, Dab-1 or Dab-1Δ PTB for 24 hours.
The cells were then treated with either 0.1% DMSO as a control (lanes 1-3), or with 50 µM of
the proteasomal inhibitor MG-132 for 6 hours (lanes 4-6), or with 100 µM of the lysosomal
inhibitor Chloroquine for 6 hours (lanes 7-9). Inhibiting the lysosome recovered APP levels in
the Dab-1 transfected cells (lane 8).
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Discussion

Recent studies have pointed to the possibility that Dab-1 may interfere with APP trafficking to
increase its cell surface expression, subjecting it to more α-secretase- and less β-secretasemediated processing, thereby, increasing α-sAPP and α-CTF levels67, 68, while reducing β-sAPP,
β-CTF and Aβ levels68.In our study, Dab-1 overexpression increased AICD release from the
membrane via increasing γ-secretase-mediated processing of APP (Figure 26).

Dab-1 is an adaptor protein that can bind the NPXY internalization motif of some
transmembrane proteins including APP via its PTB domain37,

38

. It has been shown that the

binding of Dab-1 to these proteins can regulate their trafficking76-78. In this study, we found that
the overexpression of a Dab-1 mutant that lack its PTB domain (Dab-1 ΔPTB) prevented the
lysosomal degradation of APP, indicating the importance of Dab-1 binding to APP in the
regulation of APP metabolism.

The proteasomal inhibition didn’t cause an accumulation in the level of the full length APP nor
did it rescue the reduction in its levels upon Dab-1 overexpression (Figure 32). This indicated
that APP degradation is via the lysosome rather than the proteasome (Figure 32). Thus, in
addition to Dab-1 overexpression effect on γ-secretase activity, Dab-1 seems to also enhance the
clearance of APP from the early endosomes by targeting APP to the lysosome for degradation.
This in turn can explain the observed reduction in APP-CT-GFP signals and the reduction in the
full-length levels of APP after Dab-1 overexpression.
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In conclusion, Dab-1 modulates APP metabolism and promotes α- and γ-secretase-mediated
processing of APP to release AICD without an increase in Aβ. However, the effects of Reelin
and its downstream kinases on APP degradation via the lysosome have to be investigated to
confirm the significance of the Dab-1 overexpression effects on APP. Interestingly, disrupting
APP and it’s two homologues APLP1 and APLP2 results in cortical dysplsia and neuronal
migration defects69 that are a similar but not identical to disruption of Reelin, Dab-1 or its
receptors ApoER or VLDLR18. Dab-1 may be a crucial link between some of the critical cellular
pathways in the brain; elucidating how Dab-1 mediates and links these molecules maybe a
valuable tool to understand proper brain development and AD pathology.
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CHAPTER FIVE:
GENERAL CONCLUSION
The adult mammalian brain has limited neurogenerative potential meaning that if was subjected
to an insult such a stroke, brain injury or a neurodegenerative disease, it lacks the ability to fully
regenerate the lost tissue. This will lead to the loss of the cognitive function associated with that
lost tissue. However, hope emerged with the discovery of the neural stem cells in the adult
mammalian brain as they were found to retain their abilities to divide, differentiate and migrate1.
Since the discovery of these cells, efforts have focused on increasing the potential of these cells
either via increasing their proliferative rate, stimulating their differentiation into certain type of
cells or regulating their migration into a desired site1. The therapeutic approaches can be
classified in two categories: First, expand and manipulate an exogenous source of stem cells in
vitro and then transplant these cells into the desired site. Second, stimulate the endogenous
sources of stem cells to divide, differentiate and migrate into the damaged areas1. Nevertheless,
success has been limited so far by the lack of the full understanding of the adult’s brain
environment that controls the process of functional neurogenesis.

In the adult mammalian brain neural stem cells were found to reside in two restricted regions of
the brain, these are: the subventricular zone of the lateral ventricle and the dentate gyrus of the
hippocampus1. Radial glial cells have been recently identified to be the neuronal progenitors for
most of the neurons in the CNS2, 3. The end of neurogenesis in the cortex is marked by the
transformation of the radial glial cells into astrocytes4. Reelin signaling has been recently shown
to induce the radial glial phenotype in vitro and to rescue the defects in the reeler mutant radial
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glia11. In addition, a recent study showed that the adult reeler mutants have increased
differentiation of the newly generated cells into astrocytes and decreased differentiation into
neurons22.Interestingly, Cajal-Retzius cells, cells that produce Reelin in the cortical marginal
zone, are thought to either degenerate postnatally41 or undergo developmental dilution42.

On the other hand, Notch-1 activation has been known for its role in promoting both phenotypes,
the formation of the radial glial cells and their transformation into astrocytes. Interestingly,
Notch-1 activation has been shown to induce radial glial cells differentiation prenatally and to
induce astrocytic differentiation postnatally31,

32

. Therefore, the presence of other signaling

pathways that act to induce the radial glial phenotype prenatally but are deactivated or
downregulated postnatally seems to be an attractive model to explain how Notch-1 activation
leads to different cellular fates at different developmental stages.

Accordingly, we proposed that Reelin signaling promotes Notch-1 activation to favor the radial
glial phenotype prenatally. Thus, the down-regulation of Reelin in the cortex after birth is
expected to allow the transformation of the radial glial cells into astrocytes and thereby end
cortical neurogenesis.

To test our hypothesis, we used hNPCs that were isolated from the cortex of 14 weeks old fetus.
These cells do not produce Reelin and are the end of their neurogenic phase. Our challenge was
to confirm that adding Reelin to these cells will prevent them from transforming into astrocytes
and maintain them in a neurogenic radial glial phenotype. We found that these cells respond to
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Reelin treatment by inducing BLBP expression and the subsequent formation of bipolar
morphology in the GFAP positive cells indicating the formation of neurogenic radial glia in vitro
(Figure 7). Most importantly, we found that Reelin treatment increased the neurogenic potential
of these hNPCs and significantly increased neurogenesis (Figure 13).

Next, we investigated the mechanism by which Reelin increases the formation of radial glia and
the generation of neurons. We hypothesized that Reelin induces the formation of radial glia via
activating Notch-1 signaling. We found that Reelin treatment activates Notch-1 signaling and
induces BLBP expression (Figure 9) via increasing NICD accumulation (Figure 10).
Additionally, we found that Reelin treatment enhanced the interaction between Dab-1, recently
identified as a nucleoshuttling protein50, and NICD (Figure 23) and increased NICD
translocation into the nucleus to induce BLBP expression (Figure 22).

We next questioned how Reelin modulates Notch-1 activation. The first step of the activation of
Reelin signaling is the induction of Dab-1 tyrosine phosphorylation after Reelin binds to its
receptors16. Dab-1 tyrosine phosphorylation then acts as link between Reelin and its downstream
kinases. Dab-1 tyrosine phosphorylation forms a binding site for Src family kinases resulting in
their activation.

To determine if Dab-1 tyrosine phosphorylation is crucial to mediate Reelin’s effect on Notch-1
activation, we used a Dab-1 mutant that cannot be tyrosine phosphorylated in response to
Reelin53. The use of this mutant completely abolished Reelin’s effect on Notch-1 activation and

105

brought NICD levels back to basal levels (Figure 19). Similarly, inhibiting the activity of Src
inhibited Reelin’s effect on NICD accumulation (Figure 20).

Finally, Dab-1 overexpression was found to increase the levels of α-sAPP (Figure 28). It has
been recently found that sAPP can enhance neurogenesis by increasing the proliferation of the
neuronal progenitors40. In addition, we previously found that sAPP can induce the glial
differentiation of hNSCs. These data indicate that Dab-1 may also enhance neurogenesis via
modulating the processing of APP. However, further investigations of this hypothesis are
necessary.

In conclusion, this study show that Reelin signaling, mediated by Dab-1 and Src kinase, activates
Notch-1 signaling in hNPCs resulting in the induction of BLBP expression, the formation of
radial glia and the generation of neurons. This work is novel because it provides that first
evidence that Reelin expression is an important signal for the neuronal differentiation of the
hNPCs. It also shows the crosstalk between Reelin and Notch-1 signaling, two major pathways
in development and cell fate determination. This study extends our knowledge in understanding
the role of Reelin signaling in cell fate determination, differentiation and neurogenesis and
provides us with new tools to manipulate the process of neurogenesis for neuroregenerative
therapy.
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Figure 33: A schematic diagram that summarizes the role of Reelin signaling in the
formation of neurogenic radial glia.
(1) Reelin binds to its receptors VLDLR and ApoER2 (2) initiating Dab-1 binding to the
cytoplasmic domain of VLDLR, ApoER2 and Notch-1 and leading to Dab-1 tyrosine
phosphorylation. (3) SFK binds to Dab-1 resulting in SFK activation and the (4) accumulation of
NICD. (5) NICD translocates to the nucleus and activates the transcription of BLBP. (6) BLBP
expression drives the maturation of the radial glial cell into its neurogenic phase. SFK; Src
family kinases, NICD; Notch intracellular domain, BLBP; brain lipid binding protein, Dab-1;
Disabled-1, VLDLR; very low density lipoprotein, ApoER2; ApoE receptor 2.
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